<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">78754</article-id><article-id pub-id-type="doi">10.7554/eLife.78754</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group></article-categories><title-group><article-title>Dysregulated <italic>H19/Igf2</italic> expression disrupts cardiac-placental axis during development of Silver-Russell syndrome-like mouse models</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-274360"><name><surname>Chang</surname><given-names>Suhee</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0514-3516</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-274361"><name><surname>Fulmer</surname><given-names>Diana</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7675-9951</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-274362"><name><surname>Hur</surname><given-names>Stella K</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-274363"><name><surname>Thorvaldsen</surname><given-names>Joanne L</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-274364"><name><surname>Li</surname><given-names>Li</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-296632"><name><surname>Lan</surname><given-names>Yemin</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-208617"><name><surname>Rhon-Calderon</surname><given-names>Eric A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-96645"><name><surname>Leu</surname><given-names>Nicolae Adrian</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-269081"><name><surname>Chen</surname><given-names>Xiaowen</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-145372"><name><surname>Epstein</surname><given-names>Jonathan A</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8637-4465</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-163358"><name><surname>Bartolomei</surname><given-names>Marisa S</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9410-5222</contrib-id><email>bartolom@pennmedicine.upenn.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00b30xv10</institution-id><institution>Department of Cell and Developmental Biology, Epigenetics Institute, Perelman School of Medicine, University of Pennsylvania</institution></institution-wrap><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00b30xv10</institution-id><institution>Penn Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania</institution></institution-wrap><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00b30xv10</institution-id><institution>Department of Biomedical Sciences, School of Veterinary Medicine, Institute for Regenerative Medicine, University of Pennsylvania</institution></institution-wrap><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Yan</surname><given-names>Wei</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/046rm7j60</institution-id><institution>University of California, Los Angeles</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Bronner</surname><given-names>Marianne E</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05dxps055</institution-id><institution>California Institute of Technology</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>28</day><month>11</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>11</volume><elocation-id>e78754</elocation-id><history><date date-type="received" iso-8601-date="2022-03-18"><day>18</day><month>03</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2022-11-15"><day>15</day><month>11</month><year>2022</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2022-03-28"><day>28</day><month>03</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.03.28.486058"/></event></pub-history><permissions><copyright-statement>© 2022, Chang et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Chang et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-78754-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-78754-figures-v1.pdf"/><abstract><p>Dysregulation of the imprinted <italic>H19/IGF2</italic> locus can lead to Silver-Russell syndrome (SRS) in humans. However, the mechanism of how abnormal <italic>H19/IGF2</italic> expression contributes to various SRS phenotypes remains unclear, largely due to incomplete understanding of the developmental functions of these two genes. We previously generated a mouse model with humanized <italic>H19/IGF2</italic> imprinting control region (<italic>hIC1</italic>) on the paternal allele that exhibited <italic>H19/Igf2</italic> dysregulation together with SRS-like growth restriction and perinatal lethality. Here, we dissect the role of <italic>H19</italic> and <italic>Igf2</italic> in cardiac and placental development utilizing multiple mouse models with varying levels of <italic>H19</italic> and <italic>Igf2</italic>. We report severe cardiac defects such as ventricular septal defects and thinned myocardium, placental anomalies including thrombosis and vascular malformations, together with growth restriction in mouse embryos that correlated with the extent of <italic>H19/Igf2</italic> dysregulation. Transcriptomic analysis using cardiac endothelial cells of these mouse models shows that <italic>H19/Igf2</italic> dysregulation disrupts pathways related to extracellular matrix and proliferation of endothelial cells. Our work links the heart and placenta through regulation by <italic>H19</italic> and <italic>Igf2</italic>, demonstrating that accurate dosage of both <italic>H19</italic> and <italic>Igf2</italic> is critical for normal embryonic development, especially related to the cardiac-placental axis.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>H19</kwd><kwd>Igf2</kwd><kwd>SRS</kwd><kwd>cardiac-placental axis</kwd><kwd>cardiac development</kwd><kwd>endothelial cells</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>GM-051279-28</award-id><principal-award-recipient><name><surname>Bartolomei</surname><given-names>Marisa S</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R35HL140018-05</award-id><principal-award-recipient><name><surname>Epstein</surname><given-names>Jonathan A</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000069</institution-id><institution>National Institute of Arthritis and Musculoskeletal and Skin Diseases</institution></institution-wrap></funding-source><award-id>5T32AR053461</award-id><principal-award-recipient><name><surname>Epstein</surname><given-names>Jonathan A</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Precise dosage of the imprinted <italic>H19</italic> and <italic>Igf2</italic> genes is critical for normal embryonic development, especially related to the cardiac-placental axis.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Genomic imprinting is a mammalian-specific phenomenon where a small number of genes are expressed in an allele-specific manner. Functionally, imprinted genes have central roles in development and growth in both humans and mice (<xref ref-type="bibr" rid="bib5">Barlow and Bartolomei, 2014</xref>). Additionally, proper gene dosage of most imprinted genes is essential for normal development. Human chromosome 11 and the orthologous region on mouse chromosome 7 harbor two jointly controlled growth regulators with opposing functions; <italic>H19</italic> long non-coding RNA (lncRNA) and Insulin-like Growth Factor 2 (<italic>IGF2/Igf2</italic>). These two imprinted genes share an imprinting control region (ICR), a <italic>cis</italic>-regulatory element located between two genes, which is essential for their allele-specific expression, as well as tissue-specific enhancers located downstream of <italic>H19</italic> (<xref ref-type="bibr" rid="bib8">Chang and Bartolomei, 2020</xref>). The <italic>H19/IGF2</italic> ICR, which is designated as IC1 in humans, binds CTCF on the maternal allele, forming an insulator and enabling <italic>H19</italic> exclusive access to the shared enhancers (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). On the paternal allele, the <italic>H19/IGF2</italic> ICR is methylated, which prevents CTCF from binding and an insulator from forming. Consequently, <italic>IGF2</italic> usurps the shared enhancers, and <italic>H19</italic> is repressed on the paternal allele. Ultimately, allele-specific ICR methylation facilitates monoallelic expression of <italic>H19</italic> and <italic>IGF2</italic> with <italic>H19</italic> expressed from the maternal allele and <italic>IGF2</italic> expressed from the paternal allele.</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title><italic>H19/Igf2</italic> cluster and mouse models utilized in this study.</title><p>(<bold>A</bold>) A schematic representation of the wild-type <italic>H19/Igf2</italic> cluster in mouse. The maternally expressed <italic>H19</italic> and the paternally expressed <italic>Igf2</italic> genes are shown in red and blue, respectively. Black lollipops on the paternal allele represent DNA methylation. The maternal imprinting control region (ICR) is bound to CTCF proteins (pink hexagons) at CTCF-binding sites, forming an insulator that blocks the maternal <italic>Igf2</italic> promoter from the shared enhancers (green circles). These enhancers interact with the <italic>H19</italic> promoter on the maternal allele and <italic>Igf2</italic> promoter on the paternal allele. (<bold>B</bold>) Schematic of the mouse endogenous <italic>H19/Igf2</italic> ICR, <italic>H19<sup>hIC1</sup></italic> (shortened as <italic>hIC1</italic>; <xref ref-type="bibr" rid="bib35">Hur et al., 2016</xref>), <italic>H19</italic><sup>Δ</sup><italic><sup>2.8kb-H19</sup></italic> (shortened as Δ <italic>H19</italic>), and <italic>H19</italic> <sup>Δ</sup><italic><sup>3.8kb-5’H19</sup></italic> (shortened as Δ <italic>3.8</italic>; <xref ref-type="bibr" rid="bib70">Thorvaldsen et al., 2002</xref>; <xref ref-type="bibr" rid="bib71">Thorvaldsen et al., 2006</xref>) alleles. Restriction site locations (kb) are relative to the <italic>H19</italic> transcription start site. Gray lines on the ICR represent conserved CTCF-binding sequences.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78754-fig1-v1.tif"/></fig><p>Dysregulation of the <italic>H19/IGF2</italic> cluster is associated with two growth disorders, Beckwith-Wiedemann syndrome (BWS) and Silver-Russell syndrome (SRS). In contrast to overgrowth observed for BWS, SRS is characterized by intrauterine growth restriction resulting in small for gestational age births. Other symptoms of SRS vary widely among patients and include hemihypotrophy, cognitive impairment, relative macrocephaly, and fifth-finger clinodactyly (<xref ref-type="bibr" rid="bib76">Wakeling et al., 2017</xref>). Approximately, 50% of patients with SRS exhibit IC1 hypomethylation (<xref ref-type="bibr" rid="bib17">Eggermann et al., 2011</xref>). Lack of methylation may allow the formation of an ectopic insulator on paternal IC1, which likely explains why this class of SRS individuals has biallelic <italic>H19</italic> expression and greatly diminished <italic>IGF2</italic> expression (<xref ref-type="bibr" rid="bib1">Abi Habib et al., 2017</xref>; <xref ref-type="bibr" rid="bib27">Gicquel et al., 2005</xref>). Importantly, ICR mutations in the mouse that were generated to study imprinted gene regulation provided critical information, suggesting a role for <italic>H19</italic> and <italic>IGF2</italic> in SRS. For example, mutating CpGs at CTCF sites on the paternal <italic>H19/Igf2</italic> ICR resulted in the loss of ICR methylation, activation of paternal <italic>H19</italic>, and reduced <italic>Igf2</italic> expression (<xref ref-type="bibr" rid="bib19">Engel et al., 2004</xref>). This mutation led to restricted embryonic growth, which phenocopies SRS. Nevertheless, although we and others successfully modeled a subset of SRS mutations in the mouse, not all mutations were translatable because the mouse <italic>H19</italic>/<italic>Igf2</italic> ICR lacks extensive sequence conservation with human IC1. Thus, a mouse model with human IC1 sequence substituted for the endogenous mouse <italic>H19</italic>/<italic>Igf2</italic> ICR was generated (<italic>H19<sup>hIC1</sup></italic>, shortened as <italic>hIC1</italic>; <xref ref-type="bibr" rid="bib35">Hur et al., 2016</xref>) to model human mutations more precisely (<xref ref-type="bibr" rid="bib21">Freschi et al., 2018</xref>; <xref ref-type="bibr" rid="bib22">Freschi et al., 2021</xref>). Consistent with expectations, maternally transmitted <italic>hIC1</italic> successfully maintained insulator function, suggesting the possibility to model human IC1 mutations endogenously in mice upon maternal transmission. In contrast, paternally transmitted <italic>hIC1</italic> showed loss of methylation and formation of an ectopic insulator. Consequently, paternal <italic>hIC1</italic> transmission caused elevated <italic>H19</italic> expression and <italic>Igf2</italic> depletion together with growth restriction and embryonic lethality (<xref ref-type="bibr" rid="bib35">Hur et al., 2016</xref>). Although the epigenetic defects and growth restriction of these mice nicely model SRS symptoms, many SRS individuals are viable. A potential explanation for such discrepancy between human and mouse could reflect the mosaic nature of epigenetic defects in human (<xref ref-type="bibr" rid="bib64">Soellner et al., 2019</xref>), with a subset of cells showing normal methylation patterns.</p><p>The mechanism by which <italic>H19/IGF2</italic> expression dysregulation causes SRS phenotypes is unknown, largely because the function of these two genes during development is incompletely understood. <italic>IGF2</italic> is a well-described growth factor promoting fetoplacental growth, which functions in an endocrine/paracrine manner through binding to IGF/insulin receptors (<xref ref-type="bibr" rid="bib31">Harris and Westwood, 2012</xref>). Decreased <italic>IGF2</italic> levels in patients with SRS suggest that IGF2 contributes to restricted growth in these patients (<xref ref-type="bibr" rid="bib1">Abi Habib et al., 2017</xref>; <xref ref-type="bibr" rid="bib6">Begemann et al., 2015</xref>; <xref ref-type="bibr" rid="bib27">Gicquel et al., 2005</xref>). Consistently, in mice, paternal-specific deletion of <italic>Igf2</italic> resulted in loss of <italic>Igf2</italic> expression and pre- and postnatal growth restriction (<xref ref-type="bibr" rid="bib13">DeChiara et al., 1991</xref>; <xref ref-type="bibr" rid="bib29">Haley et al., 2012</xref>). In contrast, the exact role of <italic>H19</italic> remains unclear. Previous studies in mouse suggested that <italic>H19</italic> lncRNA is a precursor for <italic>microRNA 675</italic> (<italic>Mir675</italic>), which regulates <italic>Igf1r</italic> expression (<xref ref-type="bibr" rid="bib36">Keniry et al., 2012</xref>) and that <italic>H19</italic> represses <italic>Igf2</italic> expression in trans (<xref ref-type="bibr" rid="bib23">Gabory et al., 2009</xref>). As a result, <italic>H19</italic> has been largely overlooked and suggested to be an occasional regulator of <italic>Igf2</italic> expression. Nevertheless, a previously described mouse model with <italic>H19</italic> overexpression without changes in <italic>Igf2</italic> expression showed embryonic growth restriction (<xref ref-type="bibr" rid="bib16">Drewell et al., 2000</xref>), suggesting that <italic>H19</italic> mediates growth suppression independently from <italic>Igf2</italic>. Here, we report severe developmental defects of the heart and placenta in mouse models with dysregulated <italic>H19/Igf2</italic> expression. Embryos with the paternal <italic>hIC1</italic> showed atrioventricular (AV) cushion defects in the heart coupled with ventricular septal defects (VSDs) and extremely thinned myocardial walls. Combined with placental anomalies, the cardiac defects most likely contribute to the lethality of these mice (<xref ref-type="bibr" rid="bib37">Kochilas et al., 1999</xref>; <xref ref-type="bibr" rid="bib63">Snider and Conway, 2011</xref>). Deletion of <italic>H19</italic> from the maternal allele, thereby reducing <italic>H19</italic> levels, failed to rescue completely the lethality and growth restriction associated with the paternal inheritance of <italic>hIC1</italic>. A minimal rescue of the earlier growth and resorption frequency was, however, observed with normalized <italic>H19</italic> expression. Ultimately, modifying both <italic>H19</italic> and <italic>Igf2</italic> expression was necessary to rescue most phenotypes. Transcriptomic analysis of embryonic cardiac endothelial cells identified several key signaling pathways that are affected by the dysregulated <italic>H19</italic> and <italic>Igf2</italic> and are potentially responsible for the paternal <italic>hIC1-</italic>related cardiac defects. This work emphasizes the importance of accurate dosage of <italic>H19</italic> and <italic>Igf2</italic> expression in normal cardiac and placental development, disruption of which can lead to SRS-like pathologies.</p></sec><sec id="s2" sec-type="results"><title>Results</title><p>Mouse models with genetic modifications that perturb <italic>H19</italic> and <italic>Igf2</italic> to different extents were used to address the phenotypic consequences of abnormal <italic>H19</italic> and <italic>Igf2</italic> levels (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). <italic>hIC1</italic> refers to the humanized <italic>H19<sup>hIC1</sup></italic> allele that substitutes the endogenous mouse <italic>H19/Igf2</italic> ICR with the corresponding human IC1 sequence, which was initially generated to study human BWS and SRS mutations in the mouse (<xref ref-type="bibr" rid="bib21">Freschi et al., 2018</xref>; <xref ref-type="bibr" rid="bib35">Hur et al., 2016</xref>). Paternal transmission of <italic>hIC1</italic> (<italic>+/hIC1</italic>) was previously reported to increase <italic>H19</italic> and greatly diminish <italic>Igf2</italic> expression and resulted in embryonic lethality.</p><sec id="s2-1"><title>Cardiac and placental defects in <italic>+/hIC1</italic> embryos</title><p>Our initial experiments examined the developmental phenotype of <italic>+/hIC1</italic> embryos to determine how abnormal <italic>H19/Igf2</italic> expression resulted in dramatic growth defects and lethality. As previously reported (<xref ref-type="bibr" rid="bib35">Hur et al., 2016</xref>), <italic>+/hIC1</italic> embryos showed severe growth restriction (note that for heterozygous embryos, maternal allele is written first, <xref ref-type="fig" rid="fig2">Figure 2A</xref>). The growth restriction appeared as early as E11.5 and was greatly exaggerated by the end of gestation. Although E18.5 <italic>+/hIC1</italic> embryos were observed alive and weighed approximately 40% of their wild-type littermates, <italic>+/hIC1</italic> neonates were perinatally lethal, with no live pups found on the day of birth. To ascertain the source of lethality, we first examined lungs from dead <italic>+/hIC1</italic> neonates. The lungs floated in water, demonstrating that <italic>+/hIC1</italic> pups respired after birth (<xref ref-type="bibr" rid="bib7">Borensztein et al., 2012</xref>). Additionally, <italic>+/hIC1</italic> neonates did not have a cleft palate, but no milk spots were found in their abdomen, indicating a lack of feeding.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Growth anomalies and cardiac defects of <italic>+/hIC1</italic> embryos.</title><p>(<bold>A</bold>) Fetal weight of the wild-type (blue) and <italic>+/hIC1</italic> (red) embryos at E11.5, E12.5, E14.5, E17.5, and E18.5 (mean ± SD). Each data point represents an average weight of each genotype from one litter. 8 litters for E11.5, 10 litters for E12.5, 7 litters for E14.5, 31 litters for E17.5, and 4 litters for E18.5 are presented. (<bold>B</bold>) Quantification of ventricular wall thickness (µm), measured from E17.5 wild-type and <italic>+/hIC1</italic> hearts (mean ± SD). Each data point represents an individual conceptus. Five wild-type and eight <italic>+/hIC1</italic> embryos from four different litters were examined. (<bold>C</bold>) Representative cross-sections of wild-type and <italic>+/hIC1</italic> embryonic hearts at E12.5, E15.5, and E17.5, stained with hematoxylin and eosin. All the hearts represented here are from female fetuses. Note the lack of fusion between atrioventricular (AV) cushions at E12.5, the ventricular septal defect (VSD) at E15.5, and E17.5 in <italic>+/hIC1</italic> hearts (yellow arrowheads). The boxed regions of E15.5 and E17.5 images are enlarged at the bottom of the figure, to show where the ventricular wall thickness is measured. Scale bars = 500 µm. (<bold>D</bold>) A representative image of pulmonary valves in E17.5 wild-type and <italic>+/hIC1</italic> hearts. The <italic>+/hIC1</italic> right pulmonary cusp is enlarged (yellow arrowhead), and there is no cusp in the anterior position, in contrast to the tricuspid structure in the wild-type heart. Scale bars = 500 µm. Statistics used are (<bold>A</bold>) multiple paired t-test and (<bold>B</bold>) multiple unpaired t-test with **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001, and ns = not significant.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78754-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Supplementary data for anomalies observed in +/<italic>hIC1</italic> hearts.</title><p>(<bold>A</bold>) Quantification of ventricular wall thickness (µm), measured from E15.5 wild-type and <italic>+/hIC1</italic> hearts (mean ± SD). Four wild-type and three <italic>+/hIC1</italic> embryos from two different litters were examined. Each data point represents an individual conceptus from different litters. Statistics used are multiple unpaired t-tests. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001, and ns = not significant. (<bold>B</bold>) Sequential histological sections demonstrating the bicuspid pulmonary valve (BPV) phenotype.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78754-fig2-figsupp1-v1.tif"/></fig></fig-group><p>Histological analyses were performed throughout development on major organs where <italic>H19</italic> and <italic>Igf2</italic> are highly expressed. Severe developmental defects were found in the <italic>+/hIC1</italic> heart and placenta. Cardiac defects in <italic>+/hIC1</italic> embryos were observed as early as E12.5, where the superior and inferior endocardial cushions failed to fuse into a common AV cushion (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). The cushion defect preceded incomplete interventricular septum (IVS) formation. At E15.5, a severe perimembranous VSD was observed in all five <italic>+/hIC1</italic> hearts that were evaluated (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). Importantly, this congenital heart defect resembles malformations reported in several SRS patients with IC1 hypomethylation (<xref ref-type="bibr" rid="bib26">Ghanim et al., 2013</xref>), although the prevalence is unclear and may reflect the degree of mosaicism in SRS. Additionally, E15.5 hearts showed an extremely thin myocardium (<xref ref-type="fig" rid="fig2">Figure 2C</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>). Both VSD and thinned ventricular walls persisted in E17.5 <italic>+/hIC1</italic> hearts (<xref ref-type="fig" rid="fig2">Figure 2B and C</xref>). Additionally, 6 out of 16 <italic>+/hIC1</italic> hearts in the late gestation group (E15.5 to P0) had bicuspid pulmonary valve, a rare cardiac defect in which the pulmonary valve only develops two cusps as opposed to the normal tricuspid structure (<xref ref-type="fig" rid="fig2">Figure 2D</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>). These results demonstrate that paternal <italic>hIC1</italic> transmission results in variably penetrant cardiac phenotypes. Notably, AV valvuloseptal morphogenesis, the fusion of the AV cushion and nascent septa during cardiogenesis, is required for proper cardiac septation (<xref ref-type="bibr" rid="bib18">Eisenberg and Markwald, 1995</xref>). Segmentation of the heart into four separate chambers is required to establish distinct pulmonary and systemic blood flow during heart development and is required to prevent the mixing of oxygenated and deoxygenated blood. We speculate that the failure of <italic>hIC1</italic> mutants to establish complete ventricular septation could have led to a reduced ability to provide oxygen and nutrient rich blood to the rest of the developing body (<xref ref-type="bibr" rid="bib56">Savolainen et al., 2009</xref>; <xref ref-type="bibr" rid="bib66">Spicer et al., 2014</xref>).</p><p>Another major organ with high <italic>H19/Igf2</italic> expression, which forms early in development, is the placenta. Multiple developmental defects were observed in <italic>+/hIC1</italic> placentas. As previously described (<xref ref-type="bibr" rid="bib35">Hur et al., 2016</xref>), <italic>+/hIC1</italic> placentas were growth restricted throughout development (<xref ref-type="fig" rid="fig3">Figure 3A</xref>), although the fetal to placental weight ratio was not affected through E15.5 (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>). However, at E17.5, the fetal to placental weight ratio was lower in <italic>+/hIC1</italic> conceptuses, indicating that the fetal growth restriction was more severe than the placental growth restriction as the concepti neared term (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). In addition to placental undergrowth, the junctional to labyrinth zone ratio was increased in <italic>+/hIC1</italic> placentas (<xref ref-type="fig" rid="fig3">Figure 3C</xref> and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref>), suggesting that the growth of the labyrinth layer, where the maternal-fetal exchange occurs, was more affected. Moreover, <italic>H19</italic> overexpression was exaggerated in the labyrinth in E17.5 <italic>+/hIC1</italic> placentas, while the <italic>Igf2</italic> depletion was consistent throughout the whole placenta (<xref ref-type="fig" rid="fig3">Figure 3D</xref>), possibly indicating that <italic>H19</italic> overexpression contributed disproportionately to the phenotype of growth restriction in the labyrinth. Large thrombi were observed in the labyrinth zone of these <italic>+/hIC1</italic> placentas (<xref ref-type="fig" rid="fig3">Figure 3F</xref>), in a male-skewed manner (<xref ref-type="fig" rid="fig3">Figure 3E</xref>). As the thrombi could be formed due to defective vasculature structures, wild-type and <italic>+/hIC1</italic> placentas were stained for CD34, a marker for the fetoplacental endothelial cells that line the microvessels in the labyrinth layer. Vessels in the <italic>+/hIC1</italic> labyrinth were highly dilated (<xref ref-type="fig" rid="fig3">Figure 3G</xref>), and quantification of the stained areas showed that the microvascular density was significantly decreased in <italic>+/hIC1</italic> placentas among males (<xref ref-type="fig" rid="fig3">Figure 3H</xref> and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C</xref>). Although previous studies reported that <italic>Igf2</italic>-null mice had lower placental glycogen concentration (<xref ref-type="bibr" rid="bib42">Lopez et al., 1996</xref>) and <italic>H19</italic> deletion led to increased placental glycogen storage (<xref ref-type="bibr" rid="bib20">Esquiliano et al., 2009</xref>), Periodic acid-Schiff (PAS) staining on <italic>+/hIC1</italic> placentas showed that the glycogen content is not significantly different between wild-type and <italic>+/hIC1</italic> placentas (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1D</xref>). The reduced labyrinth layer and defective microvascular expansion likely compromised the ability of <italic>+/hIC1</italic> placentas to supply nutrients and oxygen to the fetus. These results support the hypothesis that the abnormal growth of <italic>+/hIC1</italic> embryos may be explained by failure in multiple organs, especially the heart and placenta, which are developmentally linked (<xref ref-type="bibr" rid="bib4">Barak et al., 2019</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Placental defects of <italic>+/hIC1</italic> embryos.</title><p>(<bold>A</bold>) Placental weight of the wild-type (blue) and <italic>+/hIC1</italic> (red) samples at E11.5, E12.5, E14.5, E17.5, and E18.5 (mean ± SD). Each data point represents an average weight of each genotype from one litter. 3 litters for E11.5, 6 litters for E12.5, 7 litters for E14.5, 22 litters for E17.5, and 4 litters for E18.5 are presented. (<bold>B</bold>) Fetal to placental weight ratios in E17.5 wild-type and <italic>+/hIC1</italic> samples (mean ± SD). Each data point represents the average F/P ratio of each genotype from one litter. 13 litters are presented. (<bold>C</bold>) Junctional zone (Jz) to labyrinth (Lb) ratio in E17.5 wild-type and <italic>+/hIC1</italic> placentas (mean ± SD). (<bold>D</bold>) Relative total expression of <italic>H19</italic> and <italic>Igf2</italic> in E17.5 wild-type and <italic>+/hIC1</italic> placentas and Lb samples (mean ± SD). (<bold>E</bold>) Number of wild-type, male, and female <italic>+/hIC1</italic> placentas with thrombi observed. (<bold>F</bold>) Representative cross-sections of E12.5, E15.5, and E17.5 wild-type and <italic>+/hIC1</italic> placentas stained with hematoxylin and eosin. All depicted E12.5 and E15.5 placentas are female. The E17.5 wild-type placenta is female, and +/<italic>hIC1</italic> placenta is male. Black arrowhead indicates a large thrombus formed in the <italic>+/hIC1</italic> Lb. Scale bars = 1 mm. (<bold>G</bold>) Representative images of CD34 immunostaining counterstained with hematoxylin on E17.5 wild-type female and <italic>+/hIC1</italic> male placental sections. Black arrowheads indicate thrombi in the <italic>+/hIC1</italic> Lb. Scale bars = 1 mm. (<bold>H</bold>) Quantification of the microvessel density in E17.5 wild-type and <italic>+/hIC1</italic> placentas. 4 wild-type male, 10 <italic>+/hIC1</italic> male, 2 wild-type female, 8 <italic>+/hIC1</italic> female placentas from six litters were quantified. (<bold>C, D, and H</bold>) Each data point represents an individual conceptus from different litters. Statistics used are (<bold>A and B</bold>) multiple paired t-test, (<bold>C</bold>) one-way ANOVA with Tukey’s multiple comparisons test, (<bold>D and H</bold>) multiple unpaired t-test, (<bold>E</bold>) Fisher’s exact test. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001, and ns = not significant.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78754-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Supplementary data for anomalies observed in +/<italic>hIC1</italic> placentas.</title><p>(<bold>A</bold>) Fetal to placental weight ratios of the wild-type (blue) and <italic>+/hIC1</italic> (red) samples at E11.5, E12.5, E14.5, and E15.5. Each data point represents an average ratio of each genotype from one litter. (<bold>B</bold>) Junctional zone (Jz) to labyrinth (Lb) ratio in E17.5 wild-type and <italic>+/hIC1</italic> placentas. (<bold>C</bold>) Example of Lb zones that were used to quantify the microvessel density in CD34 immunostained E17.5 wild-type and <italic>+/hIC1</italic> placental sections from <xref ref-type="fig" rid="fig3">Figure 3G</xref>. Thrombi in <italic>+/hIC1</italic> placentas were excluded. (<bold>D</bold>) Left: Representative images of Periodic acid-Schiff (PAS) staining counterstained with hematoxylin on E17.5 wild-type and <italic>+/hIC1</italic> male placental sections. Right: Quantification of PAS stained images. (<bold>E</bold>) Relative total expression of <italic>Mir675-3p</italic> and <italic>Mir675-5p</italic> in E15.5 wild-type and <italic>+/hIC1</italic> placentas (mean ± SD). (<bold>B, D, and E</bold>) Each data point represents an individual conceptus from different litters. Scale bars = 1 mm. Statistics used are (<bold>A</bold>) multiple paired t-test, (<bold>B, D, and E</bold>) multiple unpaired t-tests. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001, and ns = not significant.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78754-fig3-figsupp1-v1.tif"/></fig></fig-group><p>Additionally, we examined expression of the <italic>H19-</italic>derived <italic>Mir675</italic> in <italic>+/hIC1</italic> placentas to determine if the level of <italic>Mir675</italic> is correlated with changes in <italic>H19</italic> and <italic>Igf2</italic> expression. This analysis was conducted at E15.5 when cardiac and placental defects were already observed in <italic>+/hIC1</italic> embryos (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>, B and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref>). Despite increased <italic>H19</italic> expression and <italic>Igf2</italic> depletion (<xref ref-type="bibr" rid="bib35">Hur et al., 2016</xref>), <italic>Mir675</italic> was not significantly increased in <italic>+/hIC1</italic> placentas compared to the wild-type (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1E</xref>). Thus, we conclude that the placental phenotypes observed in <italic>+/hIC1</italic> mice are solely attributable to the increased <italic>H19</italic> lncRNA, irrespective of <italic>Mir675.</italic> Another possibility is that the disproportionate <italic>H19</italic> overexpression in the labyrinth layer at E17.5 (<xref ref-type="fig" rid="fig3">Figure 3D</xref>) was also present at E15.5 because growth suppression was more severe in labyrinth than in junctional zone in E15.5 (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref>) and in E17.5 placenta (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). This would have made it difficult to detect a substantial difference in <italic>Mir675</italic> expression in the whole placenta.</p><sec id="s2-1-1"><title>Normalizing <italic>H19</italic> expression partially rescues paternal <italic>hIC1</italic> defects</title><p>It has been previously reported that <italic>Igf2</italic> null mice are viable (<xref ref-type="bibr" rid="bib13">DeChiara et al., 1991</xref>). Thus, we hypothesize that <italic>H19</italic> overexpression combined with a loss of <italic>Igf2</italic> expression is the molecular contributor to the lethality of paternal <italic>hIC1</italic> transmission. To examine if reduced <italic>H19</italic> expression would rescue the paternal <italic>hIC1</italic> transmission phenotypes, we generated a mouse model with deletion of the <italic>H19</italic> transcription unit (<italic>H19<sup>Δ2.8kb-H19</sup></italic>; shortened as Δ<italic>H19</italic>; <xref ref-type="fig" rid="fig1">Figure 1B</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A and B</xref>). Consistent with previous reports, maternal deletion of <italic>H19</italic> (<italic>ΔH19/+</italic>) led to an absence of <italic>H19</italic> expression and tissue-specific minimal activation of maternal <italic>Igf2</italic> (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C</xref>). These mice are viable and fertile, regardless of whether the deletion is maternally or paternally transmitted, although maternal transmission is associated with increased fetal weight from E14.5 and onward (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1D</xref>).</p><p>Heterozygous <italic>ΔH19</italic> females were mated with heterozygous <italic>hIC1</italic> males to generate <italic>ΔH19/hIC1</italic> embryos. These embryos were expected to have lower <italic>H19</italic> expression compared to <italic>+/hIC1</italic> embryos, as the maternal <italic>H19</italic> expression was silenced (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Among four possible genotypes from this breeding, <italic>+/hIC1</italic> embryos constituted approximately 15% per litter at E17.5, as opposed to the expected Mendelian ratio of 25%. In contrast, <italic>ΔH19/hIC1</italic> embryos comprised approximately 30% per litter at E17.5, indicating partial rescue of the resorption frequency by maternal <italic>H19</italic> deletion (<xref ref-type="fig" rid="fig4">Figure 4B</xref> and <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2A</xref>). However, <italic>ΔH19/hIC1</italic> embryos still exhibited perinatal lethality, with no live pups observed on the day of birth. With respect to growth restriction, the maternal <italic>ΔH19</italic> allele partially rescued the phenotype. At E11.5, <italic>ΔH19/hIC1</italic> fetal weight was not significantly different from wild-type littermates (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). However, at late gestation (E17.5), although <italic>ΔH19/hIC1</italic> fetuses had a significant increase in fetal weight compared to the <italic>+/hIC1</italic> fetuses, <italic>ΔH19/hIC1</italic> fetuses remained significantly smaller compared to the wild-type. As perinatal lethality was still observed, conceptuses were analyzed histologically to characterize their developmental defects. The AV cushion defect persisted in all examined E13.5 <italic>ΔH19/hIC1</italic> embryos, and 50% of the examined E17.5 <italic>ΔH19/hIC1</italic> hearts showed either perimembranous or muscular VSDs (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). Thrombi were still present in approximately 50% of <italic>ΔH19/hIC1</italic> placentas (<xref ref-type="fig" rid="fig4">Figure 4E</xref> and <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2D</xref>), and placental weight remained significantly lower compared to wild-type littermates (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2B</xref>). Of note, none of these histological defects were observed in <italic>ΔH19/+</italic> embryonic hearts and placentas (see <xref ref-type="fig" rid="fig4">Figure 4D</xref> for example; three <italic>ΔH19/+</italic> hearts each from E13.5, E15.5, and E17.5 concepti, and 20 E17.5 <italic>ΔH19/+</italic> placentas were examined). E17.5 <italic>ΔH19/hIC1</italic> tissues demonstrated wild-type levels of <italic>H19</italic> expression, while the <italic>Igf2</italic> expression remained markedly lower than wild-type (<xref ref-type="fig" rid="fig4">Figure 4F</xref> and <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2C</xref>). From these results, we conclude that restoring <italic>H19</italic> expression is not sufficient to rescue completely the lethality and developmental defects upon paternal transmission of <italic>hIC1</italic>. Thus, phenotypes are likely caused by abnormal expression of both <italic>H19</italic> and <italic>Igf2</italic>.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Normalizing <italic>H19</italic> expression through the maternal deletion of <italic>H19</italic>.</title><p>(<bold>A</bold>) A schematic representation of the rescue breeding between <italic>△H19</italic> heterozygous female and <italic>hIC1/+</italic> male mice. <italic>△H19/hIC1</italic> embryos are expected to express <italic>H19</italic> only from the paternal allele and maternally express <italic>Igf2</italic> in a tissue-specific manner. (<bold>B</bold>) Ratio of <italic>+/hIC1</italic> and <italic>△H19/hIC1</italic> embryos observed in E11.5 and E17.5 litters (mean ± SD). 8 E11.5 litters and 15 E17.5 litters with litter size larger than five pups were examined. Each data point represents one litter. (<bold>C</bold>) Relative fetal weights of wild-type, <italic>△H19/+</italic>, <italic>+/hIC1</italic>, and <italic>△H19/hIC1</italic> embryos at E11.5 and E17.5, normalized to the average body weight of the wild-type littermates (mean ± SD). (<bold>D</bold>) Representative cross-sections of wild-type, <italic>△H19/+</italic> and <italic>△H19/hIC1</italic> embryonic hearts at E13.5 and E17.5, stained with hematoxylin and eosin. Note the cushion defect at E13.5 and the ventricular septal defect (VSD) at E17.5 in <italic>△H19/hIC1</italic> hearts (yellow arrows). All E13.5 samples and E17.5 wild-type sample are male, and E17.5 <italic>△H19/+</italic> and <italic>△H19/hIC1</italic> samples are female. Scale bars = 500 µm. (<bold>E</bold>) Top: Representative cross-section of E17.5 <italic>△H19/hIC1</italic> male placenta stained with hematoxylin and eosin. Black arrowheads indicate thrombi. Scale bar = 1 mm. Bottom: Number of the wild-type, male, and female <italic>+/hIC1</italic> placentas with thrombi observed. (<bold>F</bold>) Relative total expression of <italic>H19</italic> and <italic>Igf2</italic> in E17.5 wild-type, <italic>△H19/+, +/hIC1</italic>, and <italic>△H19/hIC1</italic> hearts (mean ± SD). (<bold>C and F</bold>) Each data point represents an individual conceptus from different litters. Statistics used are (<bold>B, C, and F</bold>) one-way ANOVA with Tukey’s multiple comparisons test and (<bold>E</bold>) Fisher’s exact test. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001, and ns = not significant.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78754-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Characterization of <italic>ΔH19</italic> allele.</title><p>(<bold>A</bold>) Targeting strategy to generate the <italic>ΔH19</italic> allele. The endogenous <italic>H19</italic> locus is shown with restriction sites, gRNA locations used to generate the deletion and binding sites for probes used in Southern blot analysis (thick lines). (<bold>B</bold>) Southern blot analysis of <italic>ΔH19</italic> allele. Founder 4131 line was generated using gRNA pair A, and founder 4133 line was generated using gRNA pair B (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). 3’ probe and 5’ probe were hybridized to XbaI- and KpnI-digested DNA, respectively. The sizes of the DNA fragments are shown on the right. (<bold>C</bold>) Allele-specific <italic>Igf2</italic> expression in wild-type and <italic>ΔH19/+</italic> neonatal tongue, heart, and liver analyzed by restriction fragment length polymorphism (RFLP). Ladder, genotypes and c (<italic>Mus castaneus</italic>, paternal) and b (C57BL/6, maternal) allele controls are indicated above each gel. Quantification of band densitometry is shown below each gel, with percent of maternal allele expression relative to paternal allele indicated. No expression from the maternal <italic>Igf2</italic> allele was observed in liver. (<bold>D</bold>) Embryonic and neonatal body weight of the wild-type (blue) and <italic>ΔH19/+</italic> (green) samples at E11.5, E12.5, E14.5, E17.5, E18.5, and PN0 (mean ± SD). 6 litters for E11.5, 6 litters for E12.5, 3 litters for E14.5, 11 litters for E17.5, 3 litters for E18.5, and 14 litters for PN0 are presented. (<bold>E</bold>) Body weight of +/<italic>ΔH19</italic> neonates (mean ± SD). Three litters are presented. (<bold>D and E</bold>) Each data point represents an average weight of each genotype from one litter. Paired Student’s t-test; *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001, and ns = not significant.</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>Raw gel images for <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-78754-fig4-figsupp1-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig4s1sdata2"><label>Figure 4—figure supplement 1—source data 2.</label><caption><title>Raw gel images for <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-78754-fig4-figsupp1-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig4s1sdata3"><label>Figure 4—figure supplement 1—source data 3.</label><caption><title>Raw gel images for <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-78754-fig4-figsupp1-data3-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78754-fig4-figsupp1-v1.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>Supplementary data for rescue upon maternal <italic>ΔH19</italic> transmission.</title><p>(<bold>A</bold>) Ratio of wild-type, <italic>ΔH19/+</italic>, <italic>+/hIC1</italic>, and <italic>ΔH19/hIC1</italic> embryos observed in E11.5 and E17.5 litters (&gt;5 pups; mean ± SD). Each data point represents one litter. (<bold>B</bold>) Left: Relative placental weights of E17.5 wild-type, <italic>ΔH19/+</italic>, <italic>+/hIC1</italic>, and <italic>ΔH19/hIC1</italic> samples, normalized to the average placental weight of the wild-type littermates (mean ± SD). Right: Fetal to placental weight ratio in E17.5 wild-type, <italic>ΔH19/+</italic>, <italic>+/hIC1</italic>, and <italic>ΔH19/hIC1</italic> samples (mean ± SD). (<bold>C</bold>) Relative total expression of <italic>H19</italic> and <italic>Igf2</italic> in E17.5 wild-type, <italic>ΔH19/+</italic>, <italic>+/hIC1</italic>, and <italic>ΔH19/hIC1</italic> liver and tongue samples (mean ± SD). (<bold>D</bold>) % Area of thrombotic clots in <italic>ΔH19/hIC1</italic> placentas relative to labyrinth zone. (<bold>B and C</bold>) Each data point represents an individual conceptus from different litters. Statistics used are (<bold>A</bold>) paired Student’s t-test and (<bold>B and C</bold>) one-way ANOVA with Tukey’s multiple comparisons test; *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001, and ns = not significant.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78754-fig4-figsupp2-v1.tif"/></fig></fig-group></sec><sec id="s2-1-2"><title>Paternal <italic>hIC1</italic> defects are rescued by deletion of the maternal <italic>H19/Igf2</italic> ICR</title><p>Finally, we utilized a previously published mouse model with a 3.8 kb deletion spanning the <italic>H19/Igf2</italic> ICR (<italic>H19<sup>Δ3.8kb-5’H19</sup></italic>; shortened as <italic>Δ3.8</italic>) to modulate both <italic>H19</italic> and <italic>Igf2</italic> expression (<xref ref-type="bibr" rid="bib70">Thorvaldsen et al., 2002</xref>; <xref ref-type="bibr" rid="bib71">Thorvaldsen et al., 2006</xref>). Absence of the maternal <italic>H19/Igf2</italic> ICR activates the maternal <italic>Igf2</italic> allele and reduces <italic>H19</italic> expression. Thus, <italic>Igf2</italic> expression from the maternal allele in <italic>Δ3.8/hIC1</italic> embryos was expected to restore <italic>Igf2</italic> levels (<xref ref-type="fig" rid="fig5">Figure 5A</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Restoring <italic>H19</italic> and <italic>Igf2</italic> expression utilizing maternal <italic>H19/Igf2</italic> imprinting control region (ICR) deletion.</title><p>(<bold>A</bold>) A schematic representation of the offspring produced when <italic>△3.8</italic> heterozygous female and <italic>hIC1/+</italic> male mice are mated is depicted. <italic>△3.8/hIC1</italic> embryos are expected to show activation of maternal <italic>Igf2</italic> expression as well as paternal <italic>H19</italic> expression. (<bold>B</bold>) Relative fetal weights of wild-type, <italic>△3.8/+</italic>, <italic>+/hIC1</italic>, and <italic>△3.8/hIC1</italic> embryos at E11.5 and E17.5, normalized to the average body weight of wild-type littermates (mean ± SD). 2 E11.5 litters and 10 E17.5 litters are presented. (<bold>C</bold>) Representative cross-sections of E17.5 <italic>△3.8/+</italic> and E18.5 <italic>△3.8/hIC1</italic> embryonic hearts with ventricular septal defects (VSDs; yellow arrows), stained with hematoxylin and eosin. Sections from wild-type littermates are shown together for comparison. The E17.5 wild-type sample is male, and the rest are female. Scale bars = 500 µm. (<bold>D</bold>) Relative total expression of <italic>H19</italic> and <italic>Igf2</italic> in E17.5 wild-type, <italic>△3.8/+</italic>, <italic>+/hIC1</italic>, and <italic>△3.8/hIC1</italic> hearts (mean ± SD). (<bold>B and D</bold>) Each data point represents an individual conceptus from different litters. One-way ANOVA with Tukey’s multiple comparisons test was used with *p&lt;0.05, ***p&lt;0.001, ****p&lt;0.0001, and ns = not significant.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78754-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Supplementary data for rescue upon maternal <italic>Δ3.8</italic> transmission.</title><p>(<bold>A</bold>) Left: Relative placental weights of E17.5 wild-type, <italic>Δ3.8/+</italic>, <italic>+/hIC1</italic>, and <italic>Δ3.8/hIC1</italic> samples, normalized to the average placental weight of the wild-type littermates (mean ± SD). Right: Fetal to placental weight ratio in E17.5 wild-type, <italic>Δ3.8/+</italic>, <italic>+/hIC1</italic>, and <italic>Δ3.8/hIC1</italic> samples (mean ± SD). (<bold>B</bold>) Relative total expression of <italic>H19</italic> and <italic>Igf2</italic> in E17.5 wild-type, <italic>Δ3.8/+</italic>, <italic>+/hIC1</italic>, and <italic>Δ3.8/hIC1</italic> liver and tongue samples (mean ± SD). (<bold>C</bold>) Junctional zone (Jz) to labyrinth (Lb) ratio in E17.5 wild-type, <italic>Δ3.8/+</italic>, <italic>+/hIC1</italic>, and <italic>Δ3.8/hIC1</italic> placentas. (<bold>A, B, and C</bold>) Each data point represents an individual conceptus from different litters. One-way ANOVA with Tukey’s multiple comparisons test; *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001, and ns = not significant.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78754-fig5-figsupp1-v1.tif"/></fig></fig-group><p>Crosses between heterozygous <italic>Δ3.8</italic> females and heterozygous <italic>hIC1</italic> males produced the expected Mendelian ratio of offspring with <italic>Δ3.8/hIC1</italic> mice appearing fully viable. Both fetal and placental weights were not significantly different between <italic>Δ3.8/hIC1</italic> and wild-type concepti at E17.5 (<xref ref-type="fig" rid="fig5">Figure 5B</xref> and <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>), demonstrating full rescue of the lethality and growth restriction. However, a subset of <italic>Δ3.8/+</italic> and <italic>Δ3.8/hIC1</italic> embryonic hearts (three out of six <italic>Δ3.8/+</italic> hearts and two out of five <italic>Δ3.8/hIC1</italic> hearts) had VSDs, although the lesions in the IVS were smaller than those found in <italic>+/hIC1</italic> hearts (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). While <italic>Igf2</italic> expression in the E17.5 <italic>Δ3.8/hIC1</italic> hearts was restored to wild-type levels, normalization of <italic>H19</italic> expression varied among embryos. Although not statistically significant in heart, <italic>Δ3.8/hIC1</italic> embryos tended to have higher <italic>H19</italic> expression compared to the wild-type littermates (<xref ref-type="fig" rid="fig5">Figure 5D</xref> and <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B</xref>). These results suggest that the physiological levels of <italic>H19</italic> and <italic>Igf2</italic> expression are critical for normal cardiac development, and the variability in <italic>H19</italic> rescue could help to explain the varying penetrance of the cardiac phenotype. No thrombi were detected in the <italic>Δ3.8/hIC1</italic> placentas, and the placental morphology was normal with the junctional to labyrinth zone ratio not significantly different compared to wild-type (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C</xref>). In sum, restoring both <italic>H19</italic> and <italic>Igf2</italic> to near wild-type levels was necessary for the full rescue of the most severe pathologies of paternal <italic>hIC1</italic> transmission.</p></sec></sec><sec id="s2-2"><title>Transcriptomic analysis of cardiac endothelial cells with various <italic>H19/Igf2</italic> expression</title><p>Severe cardiac phenotypes associated with paternal <italic>hIC1</italic> transmission prompted us to question the mechanism of how dysregulated <italic>H19/Igf2</italic> causes such developmental defects. The paternal <italic>hIC1-</italic>associated cardiac phenotypes were observed as early as E12.5 when AV cushion fusion is delayed in developing hearts (<xref ref-type="fig" rid="fig2">Figure 2B</xref>), making E12.5 an optimal time point to identify the key pathways of valve development and cardiac septation that are disrupted by <italic>H19/Igf2</italic> dysregulation. Endothelial and endothelial-derived cells comprise the majority population in the AV cushion and majority non-myocyte population of the ventricular septum at E12.5 (<xref ref-type="bibr" rid="bib74">von Gise and Pu, 2012</xref>). Moreover, both <italic>H19</italic> and <italic>Igf2</italic> are strongly expressed in the endocardial layer of developing heart (<xref ref-type="bibr" rid="bib25">García-Padilla et al., 2019</xref>). Therefore, transcriptomic analysis was performed on cardiac endothelial cells of each mutant.</p><p>CD31+ cardiac endothelial cells from E12.5 wild-type, <italic>+/hIC1</italic>, <italic>ΔH19/+</italic>, <italic>ΔH19/hIC1</italic>, <italic>Δ3.8/+</italic>, and <italic>Δ3.8/hIC1</italic> embryos were collected for RNA sequencing. First, we confirmed that these six groups show gradual alteration of <italic>H19</italic>/<italic>Igf2</italic> expression (<xref ref-type="fig" rid="fig6">Figure 6A</xref>), which enabled us to generate multiple comparisons relative to <italic>H19</italic> and <italic>Igf2</italic> levels and potentially enabling attribution of phenotypes to <italic>H19</italic> or <italic>Igf2</italic>. Notably, <italic>H19</italic>/<italic>Igf2</italic> expression was indistinguishable in the wild-type and <italic>Δ3.8/hIC1</italic> samples. Additionally, there were no sex-specific differences in <italic>H19</italic>/<italic>Igf2</italic> expression across all the groups.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Transcriptomic analysis of E12.5 cardiac endothelial cells from wild-type and mutant embryos.</title><p>(<bold>A</bold>) A gradient <italic>H19</italic> and <italic>Igf2</italic> expression levels are depicted in E12.5 wild-type, <italic>+/hIC1</italic>, <italic>△H19/+</italic>, <italic>△H19/hIC1</italic>, <italic>△3.8/+</italic>, and <italic>△3.8/hIC1</italic> cardiac endothelial cells. M: male and F: female. (<bold>B</bold>) Left: Comparison between <italic>+/hIC1</italic> and the wild-type samples with a volcano plot shows 224 differentially expressed genes (DEGs) between <italic>+/hIC1</italic> and the wild-type samples. Right: Gene ontology (GO) pathways that are enriched for the 224 DEGs. (<bold>C</bold>) Immunofluorescence staining for MF20 (red) and collagen (green) on E17.5 wild-type and <italic>+/hIC1</italic> hearts. Images on the right are enlarged from the boxed area of images on the left. Scale bars = 100 µm. (<bold>D</bold>) Expression pattern of 25 genes that are differentially expressed in both male and female <italic>+/hIC1</italic> samples is compared to wild-type. (<bold>E</bold>) A volcano plot represents two DEGs between <italic>△3.8/hIC1</italic> and the wild-type samples. (<bold>F</bold>) Expression pattern of 116 genes that are commonly differentially expressed in <italic>+/hIC1</italic> compared to the wild-type and <italic>△3.8/hIC1</italic> samples.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78754-fig6-v1.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Supplementary data for differential gene expression of <italic>+/hIC1</italic> hearts.</title><p>(<bold>A</bold>) DAPI (4′,6-diamidino-2-phenylindole; blue) on E17.5 wild-type and <italic>+/hIC1</italic> hearts from <xref ref-type="fig" rid="fig6">Figure 6C</xref>. Images on the right are enlarged from the boxed area of images on the left. Scale bars = 100 µm. (<bold>B</bold>) Immunofluorescence staining for MF20 (red), collagen I (green), and DAPI (blue) on E17.5 <italic>+/hIC1</italic> hearts. Images on the right are enlarged from the boxed area of images on the left. Scale bars = 100 µm. (<bold>C</bold>) Same-sex comparisons between <italic>+/hIC1</italic> and the wild-type samples analyzed by RNA sequencing. (<bold>D</bold>) Chromosomal distribution of differentially expressed genes (DEGs) from comparisons between <italic>+/hIC1</italic> and wild-type males and females.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78754-fig6-figsupp1-v1.tif"/></fig><fig id="fig6s2" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 2.</label><caption><title>Further RNA-seq analysis involving <italic>ΔH19/hIC1</italic> endothelial cells.</title><p>(<bold>A</bold>) Volcano plot depicting comparison of <italic>ΔH19/hIC1</italic> and wild-type cardiac endothelial cells. (<bold>B</bold>) Volcano plot depicting comparison of <italic>+/hIC1</italic> and <italic>ΔH19/hIC1</italic> cardiac endothelial cells. (<bold>C</bold>) Gene ontology (GO) pathways that are enriched for 46 differentially expressed genes (DEGs) between <italic>+/hIC1</italic> and <italic>ΔH19/hIC1</italic> samples.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78754-fig6-figsupp2-v1.tif"/></fig><fig id="fig6s3" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 3.</label><caption><title>Enrichment tests for BRIDEAU_IMPRINTED_GENES using gene set enrichment analysis (GSEA).</title><p>Normalized enrichment score (NES), nominal p-value, enrichment plot, and expression heatmap of the analyzed gene set comparing (<bold>A</bold>) <italic>+/hIC1</italic> and wild-type, (<bold>B</bold>) <italic>ΔH19/+</italic> and wild-type, (<bold>C</bold>) <italic>ΔH19/hIC1</italic> and wild-type cardiac endothelial cells.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78754-fig6-figsupp3-v1.tif"/></fig><fig id="fig6s4" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 4.</label><caption><title>Further RNA-seq analysis utilizing <italic>Δ3.8/+</italic> and <italic>Δ3.8/hIC1</italic> endothelial cells.</title><p>(<bold>A</bold>) Volcano plot depicting comparison of <italic>+/hIC1</italic> and <italic>Δ3.8/hIC1</italic> cardiac endothelial cells. (<bold>B</bold>) Gene ontology (GO) pathways that are enriched for 116 differentially expressed genes (DEGs) that are commonly differentially expressed in <italic>+/hIC1</italic> compared to wild-type and <italic>Δ3.8/hIC1</italic> samples. (<bold>C</bold>) Volcano plot depicting comparison of <italic>Δ3.8/+</italic> and wild-type cardiac endothelial cells.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78754-fig6-figsupp4-v1.tif"/></fig><fig id="fig6s5" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 5.</label><caption><title>Enrichment tests for HALLMARK_HYPOXIA, GROSS_HYPOXIA_VIA_HIF1A_DN using gene set enrichment analysis (GSEA).</title><p>Normalized enrichment score (NES), nominal p-value, enrichment plot, and expression heatmap of the (<bold>A</bold>) HALLMARK_HYPOXIA, (<bold>B</bold>) GROSS_HYPOXIA_VIA_HIF1A_DN gene set comparing <italic>+/hIC1</italic> and wild-type cardiac endothelial cells.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78754-fig6-figsupp5-v1.tif"/></fig></fig-group><p>To elucidate candidate genes and cellular processes in conferring the paternal <italic>hIC1-</italic>specific cardiac phenotypes, we compared <italic>+/hIC1</italic> and wild-type samples. This comparison resulted in 224 significant differentially expressed genes (DEGs; <xref ref-type="fig" rid="fig6">Figure 6B</xref>, left). Gene ontology (GO) analysis revealed that pathways related to proliferation and remodeling of endothelial and epithelial cells are enriched in these DEGs (<xref ref-type="fig" rid="fig6">Figure 6B</xref>, right; <xref ref-type="bibr" rid="bib47">Mi et al., 2019</xref>). Notably, genes involved in extracellular matrix (ECM) and specifically, collagen matrix production, were differentially enriched in E12.5 <italic>+/hIC1</italic> samples; consistent with increased collagen in the E17.5 <italic>+/hIC1</italic> hearts, as confirmed through immunofluorescence staining (<xref ref-type="fig" rid="fig6">Figure 6C</xref>, <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A and B</xref>). Thus, differential gene expression in the presence of paternal <italic>hIC1</italic> was evidenced by E12.5 and correlated with histological consequences persisting through gestation.</p><p>Because cardiac phenotypes were indistinguishable between males and females, we next used same-sex comparisons between <italic>+/hIC1</italic> and wild-type to identify the <italic>hIC1-</italic>specific DEGs that are significant in both males and females (<xref ref-type="fig" rid="fig6">Figure 6D</xref>, left and <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1C</xref>). The 25 genes that overlapped between male and female <italic>+/hIC1-</italic>specific DEGs included <italic>Col14a1</italic>, which was upregulated in <italic>+/hIC1</italic>, emphasizing the importance of collagen-related ECM in <italic>hIC1-</italic>associated cardiac defects. The expression pattern of these 25 genes across all samples clustered <italic>+/hIC1</italic> and <italic>ΔH19/hIC1</italic>, the two groups with the most severe cardiac defects and perinatal lethality (<xref ref-type="fig" rid="fig6">Figure 6D</xref>, right). Although the number of <italic>+/hIC1-</italic>specific DEGs largely differed between males and females, there was no sex-specific bias on the X chromosome (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1D</xref>).</p><p>To separate the effect of <italic>Igf2</italic> depletion from that of <italic>H19</italic> overexpression, we utilized <italic>ΔH19/hIC1</italic> samples. Consistent with previous observations from E17.5 hearts (<xref ref-type="fig" rid="fig4">Figure 4F</xref>), <italic>ΔH19/hIC1</italic> endothelial cells exhibited low <italic>Igf2</italic>, but <italic>H19</italic> expression was not significantly different from wild-type (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2A</xref>). Thus, <italic>ΔH19/hIC1</italic> samples were compared to <italic>+/hIC1</italic> to clarify the sole effect of <italic>H19</italic> overexpression. Here, 46 DEGs were identified (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2B</xref>), which were enriched in vascular endothelial cell proliferation pathways (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2C</xref>). Surprisingly, although physiologically similar to <italic>+/hIC1</italic>, the <italic>ΔH19/hIC1</italic> transcriptome was quite different from that of <italic>+/hIC1</italic>. Compared to wild-type, <italic>ΔH19/hIC1</italic> only had 23 DEGs (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2A</xref>), in contrast to <italic>+/hIC1</italic> showing more than 200 DEGs compared to wild-type (<xref ref-type="fig" rid="fig6">Figure 6B</xref>, left). This result underscores the overwhelming effect of increased <italic>H19</italic> in transcriptomic regulation.</p><p>To identify the genes whose expression is solely affected by <italic>H19</italic>, we compared <italic>+/hIC1</italic>, <italic>ΔH19/hIC1</italic>, and <italic>ΔH19/+</italic> endothelial cells. Among 224 genes that are differentially expressed in <italic>+/hIC1</italic> endothelial cells relative to wild-type, 15 genes are also differentially expressed in <italic>ΔH19/hIC1</italic> samples, suggesting that these 15 genes were affected by the loss of <italic>Igf2</italic> rather than increased <italic>H19</italic>. Among the remaining 209 DEGs that are not altered in <italic>ΔH19</italic>/<italic>hIC1</italic> samples, only <italic>Fgf10</italic> and <italic>H19</italic> were also differentially expressed in <italic>ΔH19/+</italic> endothelial cells compared to wild-type. <italic>Fgf10</italic>, a key regulator of cardiac fibroblast development, mediates communication between cardiac progenitor cells and regulates cardiac myocyte proliferation (<xref ref-type="bibr" rid="bib33">Hubert et al., 2018</xref>; <xref ref-type="bibr" rid="bib73">Vega-Hernández et al., 2011</xref>). Consistently, <italic>Fgf10</italic> null mouse embryos showed abnormal cardiac morphology with reduced heart size and thinned ventricular wall (<xref ref-type="bibr" rid="bib52">Rochais et al., 2014</xref>; <xref ref-type="bibr" rid="bib73">Vega-Hernández et al., 2011</xref>). In our samples, <italic>Fgf10</italic> is upregulated when <italic>H19</italic> is deleted and downregulated upon <italic>H19</italic> overexpression, linking <italic>H19</italic> and <italic>Fgf10</italic> closely in the context of cardiac development. Additionally, gene set enrichment analysis revealed that the set of imprinted genes (BRIDEAU_IMPRINTED_GENES) including <italic>Cdkn1c</italic>, <italic>Dlk1</italic>, and <italic>Gatm</italic> was differentially enriched in <italic>+/hIC1</italic> samples (<xref ref-type="fig" rid="fig6s3">Figure 6—figure supplement 3A</xref>; <xref ref-type="bibr" rid="bib48">Mootha et al., 2003</xref>; <xref ref-type="bibr" rid="bib67">Subramanian et al., 2005</xref>). The same set of genes was also differentially enriched in <italic>ΔH19/+</italic> samples (<xref ref-type="fig" rid="fig6s3">Figure 6—figure supplement 3B</xref>), but not <italic>ΔH19</italic>/<italic>hIC1</italic> (<xref ref-type="fig" rid="fig6s3">Figure 6—figure supplement 3C</xref>), underscoring a role for <italic>H19</italic> as a master regulator of the imprinted gene network (<xref ref-type="bibr" rid="bib24">Gabory et al., 2010</xref>).</p><p>We then analyzed <italic>Δ3.8/hIC1</italic> samples to identify cellular processes that are required to rescue the paternal <italic>hIC1-</italic>associated lethality, as <italic>Δ3.8/hIC1</italic> mice are fully viable with occasionally observed VSD. <italic>Δ3.8/hIC1</italic> had only two DEGs compared to wild-type (<xref ref-type="fig" rid="fig6">Figure 6E</xref>). However, the <italic>Shh</italic> expression was only detected in two wild-type samples, suggesting that <italic>Shh</italic> did not have significant affect in the development of our wild-type and <italic>Δ3.8/hIC1</italic> cardiac endothelial cells at this stage. In contrast, 487 genes were differentially expressed in <italic>Δ3.8/hIC1</italic> compared to <italic>+/hIC1</italic> (<xref ref-type="fig" rid="fig6s4">Figure 6—figure supplement 4A</xref>). Within these DEGs, we wanted to clarify the genes that were likely involved in restoring viability. The 487 DEGs between <italic>+/hIC1</italic> and <italic>Δ3.8/hIC1</italic> were compared to the DEGs between <italic>+/hIC1</italic> and wild-type to filter genes that are commonly affected in both comparisons (<xref ref-type="fig" rid="fig6">Figure 6F</xref>, left). GO analysis showed that the 116 overlapping genes are associated with endothelial/epithelial cell proliferation and remodeling (<xref ref-type="fig" rid="fig6s4">Figure 6—figure supplement 4B</xref>), emphasizing the importance of the proper regulation of these pathways in the rescued viability of <italic>Δ3.8/hIC1</italic> embryos. The expression pattern of these 116 genes clustered <italic>+/hIC1</italic> and <italic>ΔH19/hIC1</italic>, implicating these genes in the perinatal lethality characteristic of these two groups (<xref ref-type="fig" rid="fig6">Figure 6F</xref>, right).</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>In this study, we report that the overexpression of <italic>H19</italic> combined with <italic>Igf2</italic> depletion leads to severe morphological defects in the heart and placenta, which are likely to be involved with the perinatal lethality and restricted growth of SRS mouse models. Genetically correcting <italic>H19</italic> was not sufficient to fully rescue the developmental defects, indicating that the SRS-like phenotypes of paternal <italic>hIC1</italic> transmission are not solely attributable to <italic>H19</italic> overexpression. Unexpectedly, although moderately adjusting both <italic>H19</italic> and <italic>Igf2</italic> rescued the lethality, septal defects persisted in some of the <italic>Δ3.8/hIC1</italic> embryos, suggesting that cardiac development is extremely sensitive to the dosage of <italic>H19</italic> and <italic>Igf2</italic>. Our transcriptomic profiling of cardiac endothelial cells with various levels of <italic>H19</italic> and <italic>Igf2</italic> expression uncovers critical pathways driven by <italic>H19</italic> and <italic>Igf2</italic> that are important for cardiac structure formation. The result suggests that the regulation of ECM and proliferation of endothelial cells are tightly regulated by <italic>H19</italic> and <italic>Igf2</italic> and potentially responsible for the paternal <italic>hIC1-</italic>associated cardiac defects.</p><p>The function of <italic>H19</italic> in cardiac development is understudied even though the expression of <italic>H19</italic> is robust in the developing endocardium and epicardium throughout gestation (<xref ref-type="bibr" rid="bib25">García-Padilla et al., 2019</xref>). Abnormal <italic>H19/Igf2</italic> expression in <italic>+/hIC1</italic> hearts disrupted AV cushion fusion, ventricular septation, and valve formation processes with variable penetrance. These events require properly established ECM, which accommodates endothelial-mesenchymal transition, cell proliferation, and cell-cell adhesion in developing hearts (<xref ref-type="bibr" rid="bib38">Kruithof et al., 2007</xref>; <xref ref-type="bibr" rid="bib68">Sullivan and Black, 2013</xref>; <xref ref-type="bibr" rid="bib74">von Gise and Pu, 2012</xref>). In adult murine hearts, where <italic>H19</italic> has been well implicated in cardiac fibrosis and remodeling (<xref ref-type="bibr" rid="bib28">Greco et al., 2016</xref>; <xref ref-type="bibr" rid="bib32">Hobuß et al., 2020</xref>; <xref ref-type="bibr" rid="bib39">Lee et al., 2011</xref>; <xref ref-type="bibr" rid="bib77">Wang et al., 2021</xref>), <italic>H19</italic> overexpression led to increased ECM and fibrosis markers after myocardial injury, while deleting <italic>H19</italic> resulted in downregulated ECM genes (<xref ref-type="bibr" rid="bib10">Choong et al., 2019</xref>). In our <italic>+/hIC1</italic> endothelial cells, the expression of several key ECM genes such as <italic>Periostin</italic> (<italic>Postn</italic>) (<xref ref-type="bibr" rid="bib62">Snider et al., 2009</xref>; <xref ref-type="bibr" rid="bib68">Sullivan and Black, 2013</xref>), <italic>Col14a1</italic>, and <italic>Adamts17</italic> (<xref ref-type="bibr" rid="bib34">Hubmacher and Apte, 2015</xref>) was significantly upregulated compared to wild-type cells. Combined with increased collagen in E17.5 <italic>+/hIC1</italic> hearts (<xref ref-type="fig" rid="fig6">Figure 6C</xref>), we hypothesize that failing to establish proper ECM contributes significantly to the <italic>+/hIC1</italic>-associated cardiac defects during development. Additionally, regulators of cell proliferation, including <italic>E2f5</italic>, <italic>Trabd2b</italic>, and <italic>Septin4</italic>, and genes associated with inflammation such as <italic>Sele</italic> and <italic>Cd200</italic> were also differentially expressed in <italic>+/hIC1</italic> samples. Overall, this work provides some hints regarding the potential mechanism underlying how increased <italic>H19</italic> expression disrupts normal cardiac development.</p><p>In contrast to the less well understood role for <italic>H19</italic>, <italic>Igf2</italic> is the main growth factor in the developing ventricular wall. Similar to <italic>H19</italic>, <italic>Igf2</italic> is highly expressed in the developing cardiac endocardium and epicardium from early gestation (<xref ref-type="bibr" rid="bib59">Shen et al., 2015</xref>) before ventricular septation is completed (<xref ref-type="bibr" rid="bib56">Savolainen et al., 2009</xref>). Deletion of <italic>Igf2</italic> and its receptors caused decreased cardiomyocyte proliferation and ventricular hypoplasia, suggesting that <italic>Igf2</italic> is the major regulator of ventricular wall thickening (<xref ref-type="bibr" rid="bib40">Li et al., 2011</xref>; <xref ref-type="bibr" rid="bib59">Shen et al., 2015</xref>). Additionally, the IVS is comprised of both mesenchymal and muscular components (<xref ref-type="bibr" rid="bib49">Penny and Vick, 2011</xref>; <xref ref-type="bibr" rid="bib66">Spicer et al., 2014</xref>), and a reduction in cardiomyocyte proliferation can lead to VSD (<xref ref-type="bibr" rid="bib63">Snider and Conway, 2011</xref>). Thus, the lack of <italic>Igf2</italic>, a growth promoter for cardiomyocytes, could have contributed to the septal defects observed in <italic>+/hIC1</italic> and <italic>ΔH19/hIC1</italic> hearts. However, the thinned myocardium in <italic>Igf2</italic> knockout mouse embryos was resolved by birth, resulting in normal cardiac morphology in neonates (<xref ref-type="bibr" rid="bib60">Shen et al., 2020</xref>). In contrast, ventricular wall thinning and septal defects in <italic>+/hIC1</italic> and <italic>ΔH19/hIC1</italic> hearts were aggravated toward the end of gestation, indicating that these phenotypes are not exclusively attributable to the loss of <italic>Igf2</italic> expression.</p><p>Recovery of <italic>Igf2</italic> expression in <italic>Δ3.8/hIC1</italic> hearts rescued ventricular hypoplasia, consistent with previous findings (<xref ref-type="bibr" rid="bib40">Li et al., 2011</xref>; <xref ref-type="bibr" rid="bib59">Shen et al., 2015</xref>). In contrast, septal defects persist in some <italic>Δ3.8/+</italic> and <italic>Δ3.8/hIC1</italic> embryos. Because <italic>Igf2</italic> expression varied substantially among <italic>Δ3.8/+</italic> and <italic>Δ3.8/hIC1</italic> hearts (<xref ref-type="fig" rid="fig5">Figure 5D</xref>), we hypothesize that the varying penetrance of septal defects in these hearts reflects the range of <italic>H19/Igf2</italic> levels. The only upregulated gene in <italic>Δ3.8/hIC1</italic> endothelial cells compared to wild-type was <italic>Cadherin 18 (Cdh18</italic>) (<xref ref-type="fig" rid="fig6">Figure 6E</xref>), which was also upregulated in <italic>Δ3.8/+</italic> samples compared to wild-type (<xref ref-type="fig" rid="fig6s4">Figure 6—figure supplement 4C</xref>) and clinically reported to be mutated in congenital heart defects (CHDs) including VSD (<xref ref-type="bibr" rid="bib9">Chen et al., 2018</xref>; <xref ref-type="bibr" rid="bib65">Soemedi et al., 2012</xref>). Although we and others showed that restoring <italic>Igf2</italic> successfully rescues the growth restriction in SRS-like mouse models (<xref ref-type="bibr" rid="bib30">Han et al., 2010</xref>; <xref ref-type="bibr" rid="bib41">Liao et al., 2021</xref>), septal defects caused by <italic>H19</italic> and <italic>Igf2</italic> dysregulation are reported for the first time in this study. Our data provide evidence that ventricular septation may be regulated separately from the ventricular wall thickening and that both events are extremely sensitive to the level of <italic>H19</italic> and <italic>Igf2</italic> expression. In humans, VSDs were found in SRS patients with IC1 hypomethylation (<xref ref-type="bibr" rid="bib26">Ghanim et al., 2013</xref>) and a patient carrying chromosomal gain of chr11p15 (<xref ref-type="bibr" rid="bib58">Serra et al., 2012</xref>). Thus, the VSD observed in our mouse models nicely models the SRS-associated CHD in human patients. It should be noted, however, that mice are often more susceptible to VSDs than humans. Mice with VSDs show a higher neonatal mortality rate, possibly due to the higher heart rates and relatively larger size of VSD lesions (<xref ref-type="bibr" rid="bib63">Snider and Conway, 2011</xref>). Additionally, cardiac defects that are lethal in mice can lead to spontaneous miscarriages in humans due to longer human gestation, making it difficult to observe human infants with similar defects.</p><p>Linked through fetoplacental blood circulation, the heart and placenta are closely connected under the cardiac-placental axis, which is crucial for fetal growth and viability (<xref ref-type="bibr" rid="bib4">Barak et al., 2019</xref>; <xref ref-type="bibr" rid="bib45">Maslen, 2018</xref>). Both organs are responsible for supplying nutrients and oxygen for developing fetuses, and placental and cardiac defects are often coupled in mouse models (<xref ref-type="bibr" rid="bib50">Perez-Garcia et al., 2018</xref>) and humans (<xref ref-type="bibr" rid="bib46">Matthiesen et al., 2016</xref>; <xref ref-type="bibr" rid="bib53">Rychik et al., 2018</xref>). Placental maintenance of a normoxic fetal environment is vital for cardiac morphogenesis, and hypoxia can lead to severe defects emerging especially in cushions and septa (<xref ref-type="bibr" rid="bib15">Dor et al., 2001</xref>). Epicardial <italic>Igf2</italic> expression in developing ventricles is induced by a normoxic environment that is dependent on the placental function (<xref ref-type="bibr" rid="bib59">Shen et al., 2015</xref>), while <italic>H19</italic> is upregulated under hypoxic conditions in mouse cardiomyocytes (<xref ref-type="bibr" rid="bib10">Choong et al., 2019</xref>). This suggests that <italic>H19</italic> and <italic>Igf2</italic> are important mediators of the interaction between heart and placenta. Consistent with previous reports, gene sets of which expression is altered under hypoxic conditions (HALLMARK_HYPOXIA, GROSS_HYPOXIA_VIA_HIF1A_DN) are differentially enriched in our <italic>+/hIC1</italic> endothelial cells compared to wild-type (<xref ref-type="fig" rid="fig6s5">Figure 6—figure supplement 5</xref>). As the heart and placenta are responsible for meeting the fetal demand for nutrients and oxygen, the malfunction of these two organs would severely constrain embryonic growth. Therefore, the precise role of <italic>H19</italic> and <italic>Igf2</italic> in cardiac-placental communication needs to be clarified to understand how the SRS-related growth restriction is induced by IC1 hypomethylation.</p><p>The labyrinth, where <italic>+/hIC1</italic> placentas show abnormal vasculature morphology and thrombosis, serves as a prime location for maternal-fetal blood exchange (<xref ref-type="bibr" rid="bib78">Woods et al., 2018</xref>). Placental thrombosis can be caused by defective labyrinth integrity, and diminished labyrinth function could limit the nutritional and oxygen supply for a fetus, which can, in turn, lead to hypoxia and growth restriction. Both <italic>H19</italic> and <italic>Igf2</italic> are highly expressed in fetoplacental endothelial cells in the labyrinth (<xref ref-type="bibr" rid="bib3">Aykroyd et al., 2022</xref>; <xref ref-type="bibr" rid="bib54">Sandovici et al., 2022</xref>). Genetically depleting <italic>Igf2</italic> expression in the epiblast lineage led to decreased labyrinth size and caused the formation of thrombi in the labyrinth, although the lesions were smaller in size than those observed in <italic>+/hIC1</italic> placentas (<xref ref-type="bibr" rid="bib54">Sandovici et al., 2022</xref>). Depletion of the placental-specific <italic>Igf2</italic> transcript in mice resulted in a smaller labyrinth and fetal growth restriction (<xref ref-type="bibr" rid="bib12">Constância et al., 2002</xref>; <xref ref-type="bibr" rid="bib61">Sibley et al., 2004</xref>), although these mice showed an increased fetal to placental weight ratio, which was decreased in <italic>+/hIC1</italic> mice. This contrasting result could be explained by the effect of the increased <italic>H19</italic> expression in <italic>+/hIC1</italic> mice. <italic>H19</italic> regulates vascular endothelial growth factor in human endothelial cells in vitro (<xref ref-type="bibr" rid="bib11">Conigliaro et al., 2015</xref>), which is involved in placental angiogenesis, specifically for the branching of fetoplacental vessels beginning at mid-gestation (<xref ref-type="bibr" rid="bib78">Woods et al., 2018</xref>). Additionally, <italic>H19</italic> is highly expressed in trophoblasts (<xref ref-type="bibr" rid="bib44">Marsh and Blelloch, 2020</xref>; <xref ref-type="bibr" rid="bib51">Poirier et al., 1991</xref>), and disrupted trophoblast development leads to defective vascular branching in the labyrinth and restricted fetal growth (<xref ref-type="bibr" rid="bib72">Ueno et al., 2013</xref>). Thus, it is possible that the morphological anomalies observed in the <italic>+/hIC1</italic> placenta are exaggerated by abnormal <italic>H19</italic> expression in trophoblasts. Transcriptomic analysis of fetoplacental endothelial cells from our mouse models would help us understand the role of <italic>H19/Igf2</italic> in placental development. Moreover, generating a tissue-specific <italic>hIC1</italic> mouse model, if possible, would allow us to determine the causal relationship between cardiac and placental phenotypes.</p><p>In summary, we provide evidence that the proper dosage of <italic>H19</italic> and <italic>Igf2</italic> is essential for normal cardiac and placental development. Investigation of the role of <italic>H19</italic> and <italic>Igf2</italic> in the cardiac-placental axis will enable a better understanding of how paternal <italic>hIC1</italic> transmission leads to the SRS-like growth restriction and perinatal lethality. As many patients with SRS exhibit DNA methylation mosaicism, the distribution of the epimutation, which reflects the severity of patient symptoms, varies. This work provides insight into identifying organs that are most sensitive to <italic>H19</italic> and <italic>Igf2</italic> dysregulation, which would allow us to develop early intervention methods for critical SRS pathologies with such variabilities.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Animal studies</title><p>All studies were approved by the Institutional Animal Care and Use Committee at the University of Pennsylvania. <italic>hIC1</italic> (<xref ref-type="bibr" rid="bib35">Hur et al., 2016</xref>) and <italic>Δ3.8</italic> (<xref ref-type="bibr" rid="bib70">Thorvaldsen et al., 2002</xref>; <xref ref-type="bibr" rid="bib71">Thorvaldsen et al., 2006</xref>) mouse models were previously described. Timed breeding was performed as previously described (<xref ref-type="bibr" rid="bib55">SanMiguel et al., 2018</xref>). Vaginal sperm plugs were checked to calculate the age, and the day of the plug was marked as E0.5. Visual staging confirmed the embryonic days at the time of dissection. All mice were maintained on C57BL/6 background for more than 10 generations if not noted otherwise.</p></sec><sec id="s4-2"><title>Generation of ΔH19 allele</title><p>Two pairs of gRNA targeting the <italic>H19</italic> gene are listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>. gRNA was prepared following a protocol from <xref ref-type="bibr" rid="bib79">Yang et al., 2014</xref> with modifications. px335 plasmid (Addgene, Watertown, MA, USA) was PCR amplified using Phusion high-fidelity DNA polymerase (New England Biolabs, Ipswich, MA, USA) and the primer set listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>. ~117 bp PCR product was gel-purified using the Gel Extraction kit (Qiagen, Hilden, Germany) according to the manufacturer’s instruction. Using the gel-purified product as template, in vitro transcription of gRNA was setup using T7 High Yield RNA Synthesis kit (New England Biolabs) according to manufacturer’s instructions. Transcribed gRNA was purified using the MEGAclear kit (Life Technologies, Carlsbad, CA, USA) according to manufacturer’s instructions. 50 ng/μl left and right single guide RNA (sgRNA) together with 100 ng/μl Cas9 mRNA was injected per zygote stage embryo by the Transgenic and Chimeric Mouse Facility at the University of Pennsylvania. The targeted allele was validated using Southern blot as previously described (<xref ref-type="bibr" rid="bib69">Thorvaldsen et al., 1998</xref>) and PCR and sequencing across junctions of <italic>ΔH19</italic> alleles. Obtained chimeras and germ line transmission animals were PCR-genotyped for the <italic>ΔH19</italic> allele using primers (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>).</p></sec><sec id="s4-3"><title>Genotyping</title><p>Mouse genomic DNA for PCR genotyping was isolated from each animal as previously described (<xref ref-type="bibr" rid="bib55">SanMiguel et al., 2018</xref>). Primers used for sex genotyping and genotyping of <italic>hIC1</italic>, <italic>Δ</italic>H19, and <italic>Δ</italic>3.8 alleles are listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>. For all genotypes, the maternal allele is listed first and the paternal allele second.</p></sec><sec id="s4-4"><title>Gene expression analysis</title><p>Mouse tissues were ground using pestles, syringes, and needles in either TRIzol (Thermo Fisher scientific, Waltham, MA, USA) or RLP buffer included in RNeasy Mini kit (Qiagen, Hilden, Germany). RNA was isolated according to the manufacturer’s instructions. cDNA synthesis, quantitative reverse transcription (qRT)-PCR, and allele-specific expression analysis was performed as previously described (<xref ref-type="bibr" rid="bib35">Hur et al., 2016</xref>). Primers and PCR conditions are listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>. Total expression levels of <italic>Mir675-3p</italic> and <italic>Mir675-5p</italic> were determined relative to snoRNA202 by using a separate RT kit (TaqMan MicroRNA Reverse Transcription Kit, Thermo Fisher Scientific), qRT-PCR primers (Assay Id 001232, 001941, 001940, Thermo Fisher Scientific), and a PCR master mix (TaqMan Universal PCR Master Mix, catalog number 4304437, Thermo Fisher Scientific) according to manufacturer’s protocol.</p></sec><sec id="s4-5"><title>Histological analysis</title><p>Mouse heart and placenta samples were collected in cold PBS, fixed overnight in 4% paraformaldehyde or 10% phosphate-buffered formalin and processed through ethanol dehydration. Tissues were paraffin-embedded and sectioned for further staining analysis. Hematoxylin and eosin staining was performed using a standard protocol. Immunohistochemistry for MF20 (Developmental Studies Hybridoma Bank, Iowa City, IA, USA) and Collagen I (cat# ab34710, Abcam, Cambridge, UK) was performed with primary antibody incubations overnight at 4°C. Prior to antibody incubation, antigen retrieval with citrate buffer was performed, followed by a 1 hr block in 10% normal serum. DAPI (cat#32670–5 MG-F, Sigma-Aldrich, St. Louis, MO, USA) was used as a counter stain, and slides were mounted with VECTASHILD (Vector, Burlingame, CA, USA). Images were taken on a Leica DMi8S widefield microscope. Placental CD34 staining and PAS staining was previously described (<xref ref-type="bibr" rid="bib75">Vrooman et al., 2020</xref>). The thickness of ventricular wall was measured on hematoxylin-eosin-stained heart sections using Adobe Photoshop. A minimum of three distinct sections were quantified for each mouse of each genotype in a blinded manner. Placental Jz/Lb ratio was measured using FIJI (ImageJ v2.0.0, <xref ref-type="bibr" rid="bib57">Schindelin et al., 2012</xref>) in a blinded manner. CD34 stained placental sections were digitally scanned using Aperio VERSA 200 platform in Comparative Pathology Core at School of Veterinary Medicine at the University of Pennsylvania. Images were analyzed via Aperio Microvessel Analysis algorithm as previously described (<xref ref-type="bibr" rid="bib75">Vrooman et al., 2020</xref>).</p></sec><sec id="s4-6"><title>RNA sequencing library preparation and analysis</title><p>E12.5 hearts were lysed with Collagenase (Sigma-Aldrich), Dispase II (Sigma-Aldrich), and DNase I (Sigma-Aldrich). Cardiac endothelial cells were collected using MACS CD31 microbeads (Miltenyi Biotec, Bergisch Gladbach, Germany), and RNA was isolated using RNeasy Micro kit (Qiagen). After confirming RNA integrity using Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA), mRNA library was generated from 25 ng RNA using NEBNext Poly(A) mRNA Magnetic Isolation Module and Ultra II RNA Library Prep Kit (New England Biolabs). Library quality was assessed by Bioanalyzer (Agilent Technologies) and TapeStation (Agilent Technologies). Sequencing was performed on NovaSeq 6000 (Illumina, San Diego, CA, USA). Quality of raw fastq reads was assessed using FastQC version 0.11.5 (<xref ref-type="bibr" rid="bib2">Andrews et al., 2015</xref>). Reads were aligned to the GRCm38/mm10 reference using STAR version 2.4.0i with default parameters and maximum fragment size of 2000 bp (<xref ref-type="bibr" rid="bib14">Dobin et al., 2013</xref>). Properly paired primary alignments were retained for downstream analysis using Samtools version 1.9. Count matrices were generated using FeatureCounts version 1.6.2 against RefSeq gene annotation and read into DESeq2 (<xref ref-type="bibr" rid="bib43">Love et al., 2014</xref>) to perform normalization and statistical analysis.</p></sec><sec id="s4-7"><title>Statistical analysis</title><p>Differences between two groups were evaluated using Student’s t-test. For three or more groups, ordinary one-way ANOVA, followed up with Tukey’s multiple comparisons test, was used. Two-sided Fisher’s exact test was used to compare the occurrence of the thrombi in the wild-type and <italic>+/hIC1</italic> placentas. All analyses were performed using GraphPad Prism software. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001, and n.s.=not significant.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Resources, Data curation, Software, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing – original draft, Project administration, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Resources, Data curation, Funding acquisition, Validation, Investigation, Visualization, Methodology, Project administration, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Conceptualization, Resources, Data curation, Investigation, Methodology</p></fn><fn fn-type="con" id="con4"><p>Conceptualization, Resources, Data curation, Validation, Investigation, Visualization, Methodology, Project administration, Writing – review and editing</p></fn><fn fn-type="con" id="con5"><p>Resources, Validation, Investigation</p></fn><fn fn-type="con" id="con6"><p>Data curation, Software, Formal analysis, Writing – review and editing</p></fn><fn fn-type="con" id="con7"><p>Resources, Data curation, Visualization, Methodology</p></fn><fn fn-type="con" id="con8"><p>Validation, Investigation, Writing – review and editing</p></fn><fn fn-type="con" id="con9"><p>Resources, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con10"><p>Resources, Supervision, Funding acquisition, Project administration, Writing – review and editing</p></fn><fn fn-type="con" id="con11"><p>Conceptualization, Resources, Data curation, Supervision, Funding acquisition, Visualization, Methodology, Writing – original draft, Project administration, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (#804211) of the University of Pennsylvania. All the animals were euthanized by carbon dioxide inhalation as recommended by National Institutes of Health. As a secondary method of euthanasia, either decapitation or cervical dislocation was performed, and every effort was made to minimize suffering.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Primers and PCR conditions utilized in this study.</title></caption><media xlink:href="elife-78754-supp1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-78754-mdarchecklist1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>Sequencing data have been deposited in GEO database under the accession number GSE199377.</p><p>The following dataset was generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>S</given-names></name><name><surname>Fulmer</surname><given-names>D</given-names></name><name><surname>Hur</surname><given-names>SK</given-names></name><name><surname>Thorvaldsen</surname><given-names>JL</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Lan</surname><given-names>Y</given-names></name><name><surname>Rhon-Calderon</surname><given-names>EA</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Epstein</surname><given-names>JA</given-names></name><name><surname>Bartolomei</surname><given-names>MS</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>Dysregulated H19/Igf2 expression disrupts cardiac-placental axis during development of Silver Russell Syndrome-like mouse models</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE199377">GSE199377</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>Authors would like to express gratitude to Christopher Krapp, Lisa Vrooman, Joel Rurik, Olga Smirnova, Jonathan Schug, Klaus Kaestner, and Colin Conine for their guidance on this study. This work was supported by National Institutes of Health grant GM-051279–28 and R35HL140018-05, National Institute of Arthritis and Musculoskeletal and Skin Diseases grant 5T32AR053461.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abi Habib</surname><given-names>W</given-names></name><name><surname>Brioude</surname><given-names>F</given-names></name><name><surname>Azzi</surname><given-names>S</given-names></name><name><surname>Salem</surname><given-names>J</given-names></name><name><surname>Das Neves</surname><given-names>C</given-names></name><name><surname>Personnier</surname><given-names>C</given-names></name><name><surname>Chantot-Bastaraud</surname><given-names>S</given-names></name><name><surname>Keren</surname><given-names>B</given-names></name><name><surname>Le Bouc</surname><given-names>Y</given-names></name><name><surname>Harbison</surname><given-names>MD</given-names></name><name><surname>Netchine</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>11P15 ICR1 partial deletions associated with igf2/H19 DMR hypomethylation and silver-russell syndrome</article-title><source>Human Mutation</source><volume>38</volume><fpage>105</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.1002/humu.23131</pub-id><pub-id pub-id-type="pmid">27701793</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Andrews</surname><given-names>S</given-names></name><name><surname>Krueger</surname><given-names>F</given-names></name><name><surname>Seconds-Pichon</surname><given-names>A</given-names></name><name><surname>Biggins</surname><given-names>F</given-names></name><name><surname>Wingett</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2015">2015</year><source>FastQC. A Quality Control Tool for High Throughput Sequence Data</source><publisher-name>Babraham Bioinformatics. Babraham Institute</publisher-name></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aykroyd</surname><given-names>BRL</given-names></name><name><surname>Tunster</surname><given-names>SJ</given-names></name><name><surname>Sferruzzi-Perri</surname><given-names>AN</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Loss of imprinting of the igf2-H19 ICR1 enhances placental endocrine capacity via sex-specific alterations in signalling pathways in the mouse</article-title><source>Development</source><volume>149</volume><elocation-id>dev199811</elocation-id><pub-id pub-id-type="doi">10.1242/dev.199811</pub-id><pub-id pub-id-type="pmid">34982814</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barak</surname><given-names>Y</given-names></name><name><surname>Hemberger</surname><given-names>M</given-names></name><name><surname>Sucov</surname><given-names>HM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Phases and mechanisms of embryonic cardiomyocyte proliferation and ventricular wall morphogenesis</article-title><source>Pediatric Cardiology</source><volume>40</volume><fpage>1359</fpage><lpage>1366</lpage><pub-id pub-id-type="doi">10.1007/s00246-019-02164-6</pub-id><pub-id pub-id-type="pmid">31342113</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barlow</surname><given-names>DP</given-names></name><name><surname>Bartolomei</surname><given-names>MS</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Genomic imprinting in mammals</article-title><source>Cold Spring Harbor Perspectives in Biology</source><volume>6</volume><elocation-id>a018382</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a018382</pub-id><pub-id pub-id-type="pmid">24492710</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Begemann</surname><given-names>M</given-names></name><name><surname>Zirn</surname><given-names>B</given-names></name><name><surname>Santen</surname><given-names>G</given-names></name><name><surname>Wirthgen</surname><given-names>E</given-names></name><name><surname>Soellner</surname><given-names>L</given-names></name><name><surname>Büttel</surname><given-names>HM</given-names></name><name><surname>Schweizer</surname><given-names>R</given-names></name><name><surname>van Workum</surname><given-names>W</given-names></name><name><surname>Binder</surname><given-names>G</given-names></name><name><surname>Eggermann</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Paternally inherited IGF2 mutation and growth restriction</article-title><source>The New England Journal of Medicine</source><volume>373</volume><fpage>349</fpage><lpage>356</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1415227</pub-id><pub-id pub-id-type="pmid">26154720</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borensztein</surname><given-names>M</given-names></name><name><surname>Viengchareun</surname><given-names>S</given-names></name><name><surname>Montarras</surname><given-names>D</given-names></name><name><surname>Journot</surname><given-names>L</given-names></name><name><surname>Binart</surname><given-names>N</given-names></name><name><surname>Lombès</surname><given-names>M</given-names></name><name><surname>Dandolo</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Double myod and IGF2 inactivation promotes brown adipose tissue development by increasing prdm16 expression</article-title><source>FASEB Journal</source><volume>26</volume><fpage>4584</fpage><lpage>4591</lpage><pub-id pub-id-type="doi">10.1096/fj.12-208496</pub-id><pub-id pub-id-type="pmid">22859371</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>S</given-names></name><name><surname>Bartolomei</surname><given-names>MS</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Modeling human epigenetic disorders in mice: beckwith-wiedemann syndrome and silver-russell syndrome</article-title><source>Disease Models &amp; Mechanisms</source><volume>13</volume><elocation-id>dmm044123</elocation-id><pub-id pub-id-type="doi">10.1242/dmm.044123</pub-id><pub-id pub-id-type="pmid">32424032</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>CP</given-names></name><name><surname>Chang</surname><given-names>SY</given-names></name><name><surname>Lin</surname><given-names>CJ</given-names></name><name><surname>Chern</surname><given-names>SR</given-names></name><name><surname>Wu</surname><given-names>PS</given-names></name><name><surname>Chen</surname><given-names>SW</given-names></name><name><surname>Lai</surname><given-names>ST</given-names></name><name><surname>Chuang</surname><given-names>TY</given-names></name><name><surname>Chen</surname><given-names>WL</given-names></name><name><surname>Yang</surname><given-names>CW</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Prenatal diagnosis of a familial 5p14.3-p14.1 deletion encompassing CDH18, CDH12, PMCHL1, PRDM9 and CDH10 in a fetus with congenital heart disease on prenatal ultrasound</article-title><source>Taiwanese Journal of Obstetrics and Gynecology</source><volume>57</volume><fpage>734</fpage><lpage>738</lpage><pub-id pub-id-type="doi">10.1016/j.tjog.2018.08.023</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choong</surname><given-names>OK</given-names></name><name><surname>Chen</surname><given-names>CY</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Lin</surname><given-names>JH</given-names></name><name><surname>Lin</surname><given-names>PJ</given-names></name><name><surname>Ruan</surname><given-names>SC</given-names></name><name><surname>Kamp</surname><given-names>TJ</given-names></name><name><surname>Hsieh</surname><given-names>PCH</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Hypoxia-induced H19/YB-1 cascade modulates cardiac remodeling after infarction</article-title><source>Theranostics</source><volume>9</volume><fpage>6550</fpage><lpage>6567</lpage><pub-id pub-id-type="doi">10.7150/thno.35218</pub-id><pub-id pub-id-type="pmid">31588235</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conigliaro</surname><given-names>A</given-names></name><name><surname>Costa</surname><given-names>V</given-names></name><name><surname>Lo Dico</surname><given-names>A</given-names></name><name><surname>Saieva</surname><given-names>L</given-names></name><name><surname>Buccheri</surname><given-names>S</given-names></name><name><surname>Dieli</surname><given-names>F</given-names></name><name><surname>Manno</surname><given-names>M</given-names></name><name><surname>Raccosta</surname><given-names>S</given-names></name><name><surname>Mancone</surname><given-names>C</given-names></name><name><surname>Tripodi</surname><given-names>M</given-names></name><name><surname>De Leo</surname><given-names>G</given-names></name><name><surname>Alessandro</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Cd90+ liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncrna</article-title><source>Molecular Cancer</source><volume>14</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1186/s12943-015-0426-x</pub-id><pub-id pub-id-type="pmid">26272696</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Constância</surname><given-names>M</given-names></name><name><surname>Hemberger</surname><given-names>M</given-names></name><name><surname>Hughes</surname><given-names>J</given-names></name><name><surname>Dean</surname><given-names>W</given-names></name><name><surname>Ferguson-Smith</surname><given-names>A</given-names></name><name><surname>Fundele</surname><given-names>R</given-names></name><name><surname>Stewart</surname><given-names>F</given-names></name><name><surname>Kelsey</surname><given-names>G</given-names></name><name><surname>Fowden</surname><given-names>A</given-names></name><name><surname>Sibley</surname><given-names>C</given-names></name><name><surname>Reik</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Placental-specific IGF-II is a major modulator of placental and fetal growth</article-title><source>Nature</source><volume>417</volume><fpage>945</fpage><lpage>948</lpage><pub-id pub-id-type="doi">10.1038/nature00819</pub-id><pub-id pub-id-type="pmid">12087403</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeChiara</surname><given-names>TM</given-names></name><name><surname>Robertson</surname><given-names>EJ</given-names></name><name><surname>Efstratiadis</surname><given-names>A</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Parental imprinting of the mouse insulin-like growth factor II gene</article-title><source>Cell</source><volume>64</volume><fpage>849</fpage><lpage>859</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(91)90513-x</pub-id><pub-id pub-id-type="pmid">1997210</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobin</surname><given-names>A</given-names></name><name><surname>Davis</surname><given-names>CA</given-names></name><name><surname>Schlesinger</surname><given-names>F</given-names></name><name><surname>Drenkow</surname><given-names>J</given-names></name><name><surname>Zaleski</surname><given-names>C</given-names></name><name><surname>Jha</surname><given-names>S</given-names></name><name><surname>Batut</surname><given-names>P</given-names></name><name><surname>Chaisson</surname><given-names>M</given-names></name><name><surname>Gingeras</surname><given-names>TR</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Star: ultrafast universal RNA-seq aligner</article-title><source>Bioinformatics</source><volume>29</volume><fpage>15</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bts635</pub-id><pub-id pub-id-type="pmid">23104886</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dor</surname><given-names>Y</given-names></name><name><surname>Camenisch</surname><given-names>TD</given-names></name><name><surname>Itin</surname><given-names>A</given-names></name><name><surname>Fishman</surname><given-names>GI</given-names></name><name><surname>McDonald</surname><given-names>JA</given-names></name><name><surname>Carmeliet</surname><given-names>P</given-names></name><name><surname>Keshet</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>A novel role for VEGF in endocardial cushion formation and its potential contribution to congenital heart defects</article-title><source>Development</source><volume>128</volume><fpage>1531</fpage><lpage>1538</lpage><pub-id pub-id-type="doi">10.1242/dev.128.9.1531</pub-id><pub-id pub-id-type="pmid">11290292</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drewell</surname><given-names>RA</given-names></name><name><surname>Brenton</surname><given-names>JD</given-names></name><name><surname>Ainscough</surname><given-names>JFX</given-names></name><name><surname>Barton</surname><given-names>SC</given-names></name><name><surname>Hilton</surname><given-names>KJ</given-names></name><name><surname>Arney</surname><given-names>KL</given-names></name><name><surname>Dandolo</surname><given-names>L</given-names></name><name><surname>Surani</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Deletion of a silencer element disrupts H19 imprinting independently of a DNA methylation epigenetic switch</article-title><source>Development</source><volume>127</volume><fpage>3419</fpage><lpage>3428</lpage><pub-id pub-id-type="doi">10.1242/dev.127.16.3419</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eggermann</surname><given-names>T</given-names></name><name><surname>Buiting</surname><given-names>K</given-names></name><name><surname>Temple</surname><given-names>IK</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Clinical utility gene card for: silver-russell syndrome</article-title><source>European Journal of Human Genetics</source><volume>19</volume><elocation-id>e202</elocation-id><pub-id pub-id-type="doi">10.1038/ejhg.2010.202</pub-id><pub-id pub-id-type="pmid">21150879</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eisenberg</surname><given-names>LM</given-names></name><name><surname>Markwald</surname><given-names>RR</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Molecular regulation of atrioventricular valvuloseptal morphogenesis</article-title><source>Circulation Research</source><volume>77</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1161/01.res.77.1.1</pub-id><pub-id pub-id-type="pmid">7788867</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engel</surname><given-names>N</given-names></name><name><surname>West</surname><given-names>AG</given-names></name><name><surname>Felsenfeld</surname><given-names>G</given-names></name><name><surname>Bartolomei</surname><given-names>MS</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Antagonism between DNA hypermethylation and enhancer-blocking activity at the H19 DMD is uncovered by cpg mutations</article-title><source>Nature Genetics</source><volume>36</volume><fpage>883</fpage><lpage>888</lpage><pub-id pub-id-type="doi">10.1038/ng1399</pub-id><pub-id pub-id-type="pmid">15273688</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esquiliano</surname><given-names>DR</given-names></name><name><surname>Guo</surname><given-names>W</given-names></name><name><surname>Liang</surname><given-names>L</given-names></name><name><surname>Dikkes</surname><given-names>P</given-names></name><name><surname>Lopez</surname><given-names>MF</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Placental glycogen stores are increased in mice with H19 null mutations but not in those with insulin or IGF type 1 receptor mutations</article-title><source>Placenta</source><volume>30</volume><fpage>693</fpage><lpage>699</lpage><pub-id pub-id-type="doi">10.1016/j.placenta.2009.05.004</pub-id><pub-id pub-id-type="pmid">19524295</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freschi</surname><given-names>A</given-names></name><name><surname>Hur</surname><given-names>SK</given-names></name><name><surname>Valente</surname><given-names>FM</given-names></name><name><surname>Ideraabdullah</surname><given-names>FY</given-names></name><name><surname>Sparago</surname><given-names>A</given-names></name><name><surname>Gentile</surname><given-names>MT</given-names></name><name><surname>Oneglia</surname><given-names>A</given-names></name><name><surname>Di Nucci</surname><given-names>D</given-names></name><name><surname>Colucci-D’Amato</surname><given-names>L</given-names></name><name><surname>Thorvaldsen</surname><given-names>JL</given-names></name><name><surname>Bartolomei</surname><given-names>MS</given-names></name><name><surname>Riccio</surname><given-names>A</given-names></name><name><surname>Cerrato</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Tissue-specific and mosaic imprinting defects underlie opposite congenital growth disorders in mice</article-title><source>PLOS Genetics</source><volume>14</volume><elocation-id>e1007243</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1007243</pub-id><pub-id pub-id-type="pmid">29470501</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freschi</surname><given-names>A</given-names></name><name><surname>Del Prete</surname><given-names>R</given-names></name><name><surname>Pignata</surname><given-names>L</given-names></name><name><surname>Cecere</surname><given-names>F</given-names></name><name><surname>Manfrevola</surname><given-names>F</given-names></name><name><surname>Mattia</surname><given-names>M</given-names></name><name><surname>Cobellis</surname><given-names>G</given-names></name><name><surname>Sparago</surname><given-names>A</given-names></name><name><surname>Bartolomei</surname><given-names>MS</given-names></name><name><surname>Riccio</surname><given-names>A</given-names></name><name><surname>Cerrato</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The number of the CTCF binding sites of the H19/IGF2:IG-DMR correlates with DNA methylation and expression imprinting in a humanized mouse model</article-title><source>Human Molecular Genetics</source><volume>30</volume><fpage>1509</fpage><lpage>1520</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddab132</pub-id><pub-id pub-id-type="pmid">34132339</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gabory</surname><given-names>A</given-names></name><name><surname>Ripoche</surname><given-names>MA</given-names></name><name><surname>Le Digarcher</surname><given-names>A</given-names></name><name><surname>Watrin</surname><given-names>F</given-names></name><name><surname>Ziyyat</surname><given-names>A</given-names></name><name><surname>Forné</surname><given-names>T</given-names></name><name><surname>Jammes</surname><given-names>H</given-names></name><name><surname>Ainscough</surname><given-names>JFX</given-names></name><name><surname>Surani</surname><given-names>MA</given-names></name><name><surname>Journot</surname><given-names>L</given-names></name><name><surname>Dandolo</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>H19 acts as a trans regulator of the imprinted gene network controlling growth in mice</article-title><source>Development</source><volume>136</volume><fpage>3413</fpage><lpage>3421</lpage><pub-id pub-id-type="doi">10.1242/dev.036061</pub-id><pub-id pub-id-type="pmid">19762426</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gabory</surname><given-names>A</given-names></name><name><surname>Jammes</surname><given-names>H</given-names></name><name><surname>Dandolo</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The H19 locus: role of an imprinted non-coding RNA in growth and development</article-title><source>BioEssays</source><volume>32</volume><fpage>473</fpage><lpage>480</lpage><pub-id pub-id-type="doi">10.1002/bies.200900170</pub-id><pub-id pub-id-type="pmid">20486133</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>García-Padilla</surname><given-names>C</given-names></name><name><surname>Domínguez</surname><given-names>JN</given-names></name><name><surname>Aránega</surname><given-names>AE</given-names></name><name><surname>Franco</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Differential chamber-specific expression and regulation of long non-coding rnas during cardiac development</article-title><source>Biochimica et Biophysica Acta. Gene Regulatory Mechanisms</source><volume>1862</volume><elocation-id>194435</elocation-id><pub-id pub-id-type="doi">10.1016/j.bbagrm.2019.194435</pub-id><pub-id pub-id-type="pmid">31678627</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghanim</surname><given-names>M</given-names></name><name><surname>Rossignol</surname><given-names>S</given-names></name><name><surname>Delobel</surname><given-names>B</given-names></name><name><surname>Irving</surname><given-names>M</given-names></name><name><surname>Miller</surname><given-names>O</given-names></name><name><surname>Devisme</surname><given-names>L</given-names></name><name><surname>Plennevaux</surname><given-names>JL</given-names></name><name><surname>Lucidarme-Rossi</surname><given-names>S</given-names></name><name><surname>Manouvrier</surname><given-names>S</given-names></name><name><surname>Salah</surname><given-names>A</given-names></name><name><surname>Chivu</surname><given-names>O</given-names></name><name><surname>Netchine</surname><given-names>I</given-names></name><name><surname>Vincent-Delorme</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Possible association between complex congenital heart defects and 11p15 hypomethylation in three patients with severe silver-russell syndrome</article-title><source>American Journal of Medical Genetics. Part A</source><volume>161A</volume><fpage>572</fpage><lpage>577</lpage><pub-id pub-id-type="doi">10.1002/ajmg.a.35691</pub-id><pub-id pub-id-type="pmid">23401077</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gicquel</surname><given-names>C</given-names></name><name><surname>Rossignol</surname><given-names>S</given-names></name><name><surname>Cabrol</surname><given-names>S</given-names></name><name><surname>Houang</surname><given-names>M</given-names></name><name><surname>Steunou</surname><given-names>V</given-names></name><name><surname>Barbu</surname><given-names>V</given-names></name><name><surname>Danton</surname><given-names>F</given-names></name><name><surname>Thibaud</surname><given-names>N</given-names></name><name><surname>Le Merrer</surname><given-names>M</given-names></name><name><surname>Burglen</surname><given-names>L</given-names></name><name><surname>Bertrand</surname><given-names>AM</given-names></name><name><surname>Netchine</surname><given-names>I</given-names></name><name><surname>Le Bouc</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Epimutation of the telomeric imprinting center region on chromosome 11p15 in silver-russell syndrome</article-title><source>Nature Genetics</source><volume>37</volume><fpage>1003</fpage><lpage>1007</lpage><pub-id pub-id-type="doi">10.1038/ng1629</pub-id><pub-id pub-id-type="pmid">16086014</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greco</surname><given-names>S</given-names></name><name><surname>Zaccagnini</surname><given-names>G</given-names></name><name><surname>Perfetti</surname><given-names>A</given-names></name><name><surname>Fuschi</surname><given-names>P</given-names></name><name><surname>Valaperta</surname><given-names>R</given-names></name><name><surname>Voellenkle</surname><given-names>C</given-names></name><name><surname>Castelvecchio</surname><given-names>S</given-names></name><name><surname>Gaetano</surname><given-names>C</given-names></name><name><surname>Finato</surname><given-names>N</given-names></name><name><surname>Beltrami</surname><given-names>AP</given-names></name><name><surname>Menicanti</surname><given-names>L</given-names></name><name><surname>Martelli</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Long noncoding RNA dysregulation in ischemic heart failure</article-title><source>Journal of Translational Medicine</source><volume>14</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1186/s12967-016-0926-5</pub-id><pub-id pub-id-type="pmid">27317124</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haley</surname><given-names>VL</given-names></name><name><surname>Barnes</surname><given-names>DJ</given-names></name><name><surname>Sandovici</surname><given-names>I</given-names></name><name><surname>Constancia</surname><given-names>M</given-names></name><name><surname>Graham</surname><given-names>CF</given-names></name><name><surname>Pezzella</surname><given-names>F</given-names></name><name><surname>Bühnemann</surname><given-names>C</given-names></name><name><surname>Carter</surname><given-names>EJ</given-names></name><name><surname>Hassan</surname><given-names>AB</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Igf2 pathway dependency of the trp53 developmental and tumour phenotypes</article-title><source>EMBO Molecular Medicine</source><volume>4</volume><fpage>705</fpage><lpage>718</lpage><pub-id pub-id-type="doi">10.1002/emmm.201101105</pub-id><pub-id pub-id-type="pmid">22674894</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>L</given-names></name><name><surname>Szabó</surname><given-names>PE</given-names></name><name><surname>Mann</surname><given-names>JR</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Postnatal survival of mice with maternal duplication of distal chromosome 7 induced by a igf2/H19 imprinting control region lacking insulator function</article-title><source>PLOS Genetics</source><volume>6</volume><elocation-id>e1000803</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1000803</pub-id><pub-id pub-id-type="pmid">20062522</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>LK</given-names></name><name><surname>Westwood</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Biology and significance of signalling pathways activated by IGF-II</article-title><source>Growth Factors</source><volume>30</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.3109/08977194.2011.640325</pub-id><pub-id pub-id-type="pmid">22136428</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hobuß</surname><given-names>L</given-names></name><name><surname>Foinquinos</surname><given-names>A</given-names></name><name><surname>Jung</surname><given-names>M</given-names></name><name><surname>Kenneweg</surname><given-names>F</given-names></name><name><surname>Xiao</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Zimmer</surname><given-names>K</given-names></name><name><surname>Remke</surname><given-names>J</given-names></name><name><surname>Just</surname><given-names>A</given-names></name><name><surname>Nowak</surname><given-names>J</given-names></name><name><surname>Schmidt</surname><given-names>A</given-names></name><name><surname>Pich</surname><given-names>A</given-names></name><name><surname>Mazlan</surname><given-names>S</given-names></name><name><surname>Reamon-Buettner</surname><given-names>SM</given-names></name><name><surname>Ramos</surname><given-names>GC</given-names></name><name><surname>Frantz</surname><given-names>S</given-names></name><name><surname>Viereck</surname><given-names>J</given-names></name><name><surname>Loyer</surname><given-names>X</given-names></name><name><surname>Boulanger</surname><given-names>C</given-names></name><name><surname>Wollert</surname><given-names>KC</given-names></name><name><surname>Fiedler</surname><given-names>J</given-names></name><name><surname>Thum</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Pleiotropic cardiac functions controlled by ischemia-induced lncrna H19</article-title><source>Journal of Molecular and Cellular Cardiology</source><volume>146</volume><fpage>43</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2020.07.001</pub-id><pub-id pub-id-type="pmid">32649928</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hubert</surname><given-names>F</given-names></name><name><surname>Payan</surname><given-names>SM</given-names></name><name><surname>Rochais</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>FGF10 signaling in heart development, homeostasis, disease and repair</article-title><source>Frontiers in Genetics</source><volume>9</volume><elocation-id>599</elocation-id><pub-id pub-id-type="doi">10.3389/fgene.2018.00599</pub-id><pub-id pub-id-type="pmid">30546382</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hubmacher</surname><given-names>D</given-names></name><name><surname>Apte</surname><given-names>SS</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>ADAMTS proteins as modulators of microfibril formation and function</article-title><source>Matrix Biology</source><volume>47</volume><fpage>34</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1016/j.matbio.2015.05.004</pub-id><pub-id pub-id-type="pmid">25957949</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hur</surname><given-names>SK</given-names></name><name><surname>Freschi</surname><given-names>A</given-names></name><name><surname>Ideraabdullah</surname><given-names>F</given-names></name><name><surname>Thorvaldsen</surname><given-names>JL</given-names></name><name><surname>Luense</surname><given-names>LJ</given-names></name><name><surname>Weller</surname><given-names>AH</given-names></name><name><surname>Berger</surname><given-names>SL</given-names></name><name><surname>Cerrato</surname><given-names>F</given-names></name><name><surname>Riccio</surname><given-names>A</given-names></name><name><surname>Bartolomei</surname><given-names>MS</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Humanized H19/igf2 locus reveals diverged imprinting mechanism between mouse and human and reflects silver-russell syndrome phenotypes</article-title><source>PNAS</source><volume>113</volume><fpage>10938</fpage><lpage>10943</lpage><pub-id pub-id-type="doi">10.1073/pnas.1603066113</pub-id><pub-id pub-id-type="pmid">27621468</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keniry</surname><given-names>A</given-names></name><name><surname>Oxley</surname><given-names>D</given-names></name><name><surname>Monnier</surname><given-names>P</given-names></name><name><surname>Kyba</surname><given-names>M</given-names></name><name><surname>Dandolo</surname><given-names>L</given-names></name><name><surname>Smits</surname><given-names>G</given-names></name><name><surname>Reik</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The H19 lincrna is a developmental reservoir of mir-675 that suppresses growth and IGF1R</article-title><source>Nature Cell Biology</source><volume>14</volume><fpage>659</fpage><lpage>665</lpage><pub-id pub-id-type="doi">10.1038/ncb2521</pub-id><pub-id pub-id-type="pmid">22684254</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kochilas</surname><given-names>LK</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Jin</surname><given-names>F</given-names></name><name><surname>Buck</surname><given-names>CA</given-names></name><name><surname>Epstein</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>P57Kip2 expression is enhanced during mid-cardiac murine development and is restricted to trabecular myocardium</article-title><source>Pediatric Research</source><volume>45</volume><fpage>635</fpage><lpage>642</lpage><pub-id pub-id-type="doi">10.1203/00006450-199905010-00004</pub-id><pub-id pub-id-type="pmid">10231856</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kruithof</surname><given-names>BPT</given-names></name><name><surname>Krawitz</surname><given-names>SA</given-names></name><name><surname>Gaussin</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Atrioventricular valve development during late embryonic and postnatal stages involves condensation and extracellular matrix remodeling</article-title><source>Developmental Biology</source><volume>302</volume><fpage>208</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2006.09.024</pub-id><pub-id pub-id-type="pmid">17054936</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Gao</surname><given-names>C</given-names></name><name><surname>Peng</surname><given-names>G</given-names></name><name><surname>Greer</surname><given-names>C</given-names></name><name><surname>Ren</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Xiao</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Analysis of transcriptome complexity through RNA sequencing in normal and failing murine hearts</article-title><source>Circulation Research</source><volume>109</volume><fpage>1332</fpage><lpage>1341</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.111.249433</pub-id><pub-id pub-id-type="pmid">22034492</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Cavallero</surname><given-names>S</given-names></name><name><surname>Gu</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>THP</given-names></name><name><surname>Hughes</surname><given-names>J</given-names></name><name><surname>Hassan</surname><given-names>AB</given-names></name><name><surname>Brüning</surname><given-names>JC</given-names></name><name><surname>Pashmforoush</surname><given-names>M</given-names></name><name><surname>Sucov</surname><given-names>HM</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Igf signaling directs ventricular cardiomyocyte proliferation during embryonic heart development</article-title><source>Development</source><volume>138</volume><fpage>1795</fpage><lpage>1805</lpage><pub-id pub-id-type="doi">10.1242/dev.054338</pub-id><pub-id pub-id-type="pmid">21429986</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>J</given-names></name><name><surname>Zeng</surname><given-names>TB</given-names></name><name><surname>Pierce</surname><given-names>N</given-names></name><name><surname>Tran</surname><given-names>DA</given-names></name><name><surname>Singh</surname><given-names>P</given-names></name><name><surname>Mann</surname><given-names>JR</given-names></name><name><surname>Szabó</surname><given-names>PE</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Prenatal correction of IGF2 to rescue the growth phenotypes in mouse models of beckwith-wiedemann and silver-russell syndromes</article-title><source>Cell Reports</source><volume>34</volume><elocation-id>108729</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2021.108729</pub-id><pub-id pub-id-type="pmid">33567274</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopez</surname><given-names>MF</given-names></name><name><surname>Dikkes</surname><given-names>P</given-names></name><name><surname>Zurakowski</surname><given-names>D</given-names></name><name><surname>Villa-Komaroff</surname><given-names>L</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Insulin-like growth factor II affects the appearance and glycogen content of glycogen cells in the murine placenta</article-title><source>Endocrinology</source><volume>137</volume><fpage>2100</fpage><lpage>2108</lpage><pub-id pub-id-type="doi">10.1210/endo.137.5.8612553</pub-id><pub-id pub-id-type="pmid">8612553</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Love</surname><given-names>MI</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name><name><surname>Anders</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Moderated estimation of fold change and dispersion for RNA-seq data with deseq2</article-title><source>Genome Biology</source><volume>15</volume><elocation-id>550</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id><pub-id pub-id-type="pmid">25516281</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marsh</surname><given-names>B</given-names></name><name><surname>Blelloch</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Single nuclei RNA-seq of mouse placental labyrinth development</article-title><source>eLife</source><volume>9</volume><elocation-id>e60266</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.60266</pub-id><pub-id pub-id-type="pmid">33141023</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maslen</surname><given-names>CL</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Recent advances in placenta-heart interactions</article-title><source>Frontiers in Physiology</source><volume>9</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.3389/fphys.2018.00735</pub-id><pub-id pub-id-type="pmid">29962966</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matthiesen</surname><given-names>NB</given-names></name><name><surname>Henriksen</surname><given-names>TB</given-names></name><name><surname>Agergaard</surname><given-names>P</given-names></name><name><surname>Gaynor</surname><given-names>JW</given-names></name><name><surname>Bach</surname><given-names>CC</given-names></name><name><surname>Hjortdal</surname><given-names>VE</given-names></name><name><surname>Østergaard</surname><given-names>JR</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Congenital heart defects and indices of placental and fetal growth in a nationwide study of 924 422 liveborn infants</article-title><source>Circulation</source><volume>134</volume><fpage>1546</fpage><lpage>1556</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.116.021793</pub-id><pub-id pub-id-type="pmid">27742737</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mi</surname><given-names>H</given-names></name><name><surname>Muruganujan</surname><given-names>A</given-names></name><name><surname>Ebert</surname><given-names>D</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Thomas</surname><given-names>PD</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Panther version 14: more genomes, a new panther GO-slim and improvements in enrichment analysis tools</article-title><source>Nucleic Acids Research</source><volume>47</volume><fpage>D419</fpage><lpage>D426</lpage><pub-id pub-id-type="doi">10.1093/nar/gky1038</pub-id><pub-id pub-id-type="pmid">30407594</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mootha</surname><given-names>VK</given-names></name><name><surname>Lindgren</surname><given-names>CM</given-names></name><name><surname>Eriksson</surname><given-names>KF</given-names></name><name><surname>Subramanian</surname><given-names>A</given-names></name><name><surname>Sihag</surname><given-names>S</given-names></name><name><surname>Lehar</surname><given-names>J</given-names></name><name><surname>Puigserver</surname><given-names>P</given-names></name><name><surname>Carlsson</surname><given-names>E</given-names></name><name><surname>Ridderstråle</surname><given-names>M</given-names></name><name><surname>Laurila</surname><given-names>E</given-names></name><name><surname>Houstis</surname><given-names>N</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name><name><surname>Patterson</surname><given-names>N</given-names></name><name><surname>Mesirov</surname><given-names>JP</given-names></name><name><surname>Golub</surname><given-names>TR</given-names></name><name><surname>Tamayo</surname><given-names>P</given-names></name><name><surname>Spiegelman</surname><given-names>B</given-names></name><name><surname>Lander</surname><given-names>ES</given-names></name><name><surname>Hirschhorn</surname><given-names>JN</given-names></name><name><surname>Altshuler</surname><given-names>D</given-names></name><name><surname>Groop</surname><given-names>LC</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes</article-title><source>Nature Genetics</source><volume>34</volume><fpage>267</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1038/ng1180</pub-id><pub-id pub-id-type="pmid">12808457</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Penny</surname><given-names>DJ</given-names></name><name><surname>Vick</surname><given-names>GW</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Ventricular septal defect</article-title><source>The Lancet</source><volume>377</volume><fpage>1103</fpage><lpage>1112</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(10)61339-6</pub-id><pub-id pub-id-type="pmid">21349577</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perez-Garcia</surname><given-names>V</given-names></name><name><surname>Fineberg</surname><given-names>E</given-names></name><name><surname>Wilson</surname><given-names>R</given-names></name><name><surname>Murray</surname><given-names>A</given-names></name><name><surname>Mazzeo</surname><given-names>CI</given-names></name><name><surname>Tudor</surname><given-names>C</given-names></name><name><surname>Sienerth</surname><given-names>A</given-names></name><name><surname>White</surname><given-names>JK</given-names></name><name><surname>Tuck</surname><given-names>E</given-names></name><name><surname>Ryder</surname><given-names>EJ</given-names></name><name><surname>Gleeson</surname><given-names>D</given-names></name><name><surname>Siragher</surname><given-names>E</given-names></name><name><surname>Wardle-Jones</surname><given-names>H</given-names></name><name><surname>Staudt</surname><given-names>N</given-names></name><name><surname>Wali</surname><given-names>N</given-names></name><name><surname>Collins</surname><given-names>J</given-names></name><name><surname>Geyer</surname><given-names>S</given-names></name><name><surname>Busch-Nentwich</surname><given-names>EM</given-names></name><name><surname>Galli</surname><given-names>A</given-names></name><name><surname>Smith</surname><given-names>JC</given-names></name><name><surname>Robertson</surname><given-names>E</given-names></name><name><surname>Adams</surname><given-names>DJ</given-names></name><name><surname>Weninger</surname><given-names>WJ</given-names></name><name><surname>Mohun</surname><given-names>T</given-names></name><name><surname>Hemberger</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Placentation defects are highly prevalent in embryonic lethal mouse mutants</article-title><source>Nature</source><volume>555</volume><fpage>463</fpage><lpage>468</lpage><pub-id pub-id-type="doi">10.1038/nature26002</pub-id><pub-id pub-id-type="pmid">29539633</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poirier</surname><given-names>F</given-names></name><name><surname>Chan</surname><given-names>CTJ</given-names></name><name><surname>Timmons</surname><given-names>PM</given-names></name><name><surname>Robertson</surname><given-names>EJ</given-names></name><name><surname>Evans</surname><given-names>MJ</given-names></name><name><surname>Rigby</surname><given-names>PWJ</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>The murine H19 gene is activated during embryonic stem cell differentiation in vitro and at the time of implantation in the developing embryo</article-title><source>Development</source><volume>113</volume><fpage>1105</fpage><lpage>1114</lpage><pub-id pub-id-type="doi">10.1242/dev.113.4.1105</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rochais</surname><given-names>F</given-names></name><name><surname>Sturny</surname><given-names>R</given-names></name><name><surname>Chao</surname><given-names>CM</given-names></name><name><surname>Mesbah</surname><given-names>K</given-names></name><name><surname>Bennett</surname><given-names>M</given-names></name><name><surname>Mohun</surname><given-names>TJ</given-names></name><name><surname>Bellusci</surname><given-names>S</given-names></name><name><surname>Kelly</surname><given-names>RG</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Fgf10 promotes regional foetal cardiomyocyte proliferation and adult cardiomyocyte cell-cycle re-entry</article-title><source>Cardiovascular Research</source><volume>104</volume><fpage>432</fpage><lpage>442</lpage><pub-id pub-id-type="doi">10.1093/cvr/cvu232</pub-id><pub-id pub-id-type="pmid">25344367</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rychik</surname><given-names>J</given-names></name><name><surname>Goff</surname><given-names>D</given-names></name><name><surname>McKay</surname><given-names>E</given-names></name><name><surname>Mott</surname><given-names>A</given-names></name><name><surname>Tian</surname><given-names>Z</given-names></name><name><surname>Licht</surname><given-names>DJ</given-names></name><name><surname>Gaynor</surname><given-names>JW</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Characterization of the placenta in the newborn with congenital heart disease: distinctions based on type of cardiac malformation</article-title><source>Pediatric Cardiology</source><volume>39</volume><fpage>1165</fpage><lpage>1171</lpage><pub-id pub-id-type="doi">10.1007/s00246-018-1876-x</pub-id><pub-id pub-id-type="pmid">29728721</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandovici</surname><given-names>I</given-names></name><name><surname>Georgopoulou</surname><given-names>A</given-names></name><name><surname>Pérez-García</surname><given-names>V</given-names></name><name><surname>Hufnagel</surname><given-names>A</given-names></name><name><surname>López-Tello</surname><given-names>J</given-names></name><name><surname>Lam</surname><given-names>BYH</given-names></name><name><surname>Schiefer</surname><given-names>SN</given-names></name><name><surname>Gaudreau</surname><given-names>C</given-names></name><name><surname>Santos</surname><given-names>F</given-names></name><name><surname>Hoelle</surname><given-names>K</given-names></name><name><surname>Yeo</surname><given-names>GSH</given-names></name><name><surname>Burling</surname><given-names>K</given-names></name><name><surname>Reiterer</surname><given-names>M</given-names></name><name><surname>Fowden</surname><given-names>AL</given-names></name><name><surname>Burton</surname><given-names>GJ</given-names></name><name><surname>Branco</surname><given-names>CM</given-names></name><name><surname>Sferruzzi-Perri</surname><given-names>AN</given-names></name><name><surname>Constância</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>The imprinted igf2-igf2r axis is critical for matching placental microvasculature expansion to fetal growth</article-title><source>Developmental Cell</source><volume>57</volume><fpage>63</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2021.12.005</pub-id><pub-id pub-id-type="pmid">34963058</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>SanMiguel</surname><given-names>JM</given-names></name><name><surname>Abramowitz</surname><given-names>LK</given-names></name><name><surname>Bartolomei</surname><given-names>MS</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Imprinted gene dysregulation in a tet1 null mouse model is stochastic and variable in the germline and offspring</article-title><source>Development</source><volume>145</volume><elocation-id>dev160622</elocation-id><pub-id pub-id-type="doi">10.1242/dev.160622</pub-id><pub-id pub-id-type="pmid">29530881</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savolainen</surname><given-names>SM</given-names></name><name><surname>Foley</surname><given-names>JF</given-names></name><name><surname>Elmore</surname><given-names>SA</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Histology atlas of the developing mouse heart with emphasis on E11.5 to E18.5</article-title><source>Toxicologic Pathology</source><volume>37</volume><fpage>395</fpage><lpage>414</lpage><pub-id pub-id-type="doi">10.1177/0192623309335060</pub-id><pub-id pub-id-type="pmid">19359541</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schindelin</surname><given-names>J</given-names></name><name><surname>Arganda-Carreras</surname><given-names>I</given-names></name><name><surname>Frise</surname><given-names>E</given-names></name><name><surname>Kaynig</surname><given-names>V</given-names></name><name><surname>Longair</surname><given-names>M</given-names></name><name><surname>Pietzsch</surname><given-names>T</given-names></name><name><surname>Preibisch</surname><given-names>S</given-names></name><name><surname>Rueden</surname><given-names>C</given-names></name><name><surname>Saalfeld</surname><given-names>S</given-names></name><name><surname>Schmid</surname><given-names>B</given-names></name><name><surname>Tinevez</surname><given-names>JY</given-names></name><name><surname>White</surname><given-names>DJ</given-names></name><name><surname>Hartenstein</surname><given-names>V</given-names></name><name><surname>Eliceiri</surname><given-names>K</given-names></name><name><surname>Tomancak</surname><given-names>P</given-names></name><name><surname>Cardona</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Fiji: an open-source platform for biological-image analysis</article-title><source>Nature Methods</source><volume>9</volume><fpage>676</fpage><lpage>682</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2019</pub-id><pub-id pub-id-type="pmid">22743772</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serra</surname><given-names>A</given-names></name><name><surname>Eirich</surname><given-names>K</given-names></name><name><surname>Winkler</surname><given-names>AK</given-names></name><name><surname>Mrasek</surname><given-names>K</given-names></name><name><surname>Göhring</surname><given-names>G</given-names></name><name><surname>Barbi</surname><given-names>G</given-names></name><name><surname>Cario</surname><given-names>H</given-names></name><name><surname>Schlegelberger</surname><given-names>B</given-names></name><name><surname>Pokora</surname><given-names>B</given-names></name><name><surname>Liehr</surname><given-names>T</given-names></name><name><surname>Leriche</surname><given-names>C</given-names></name><name><surname>Henne-Bruns</surname><given-names>D</given-names></name><name><surname>Barth</surname><given-names>TF</given-names></name><name><surname>Schindler</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Shared copy number variation in simultaneous nephroblastoma and neuroblastoma due to fanconi anemia</article-title><source>Molecular Syndromology</source><volume>3</volume><fpage>120</fpage><lpage>130</lpage><pub-id pub-id-type="doi">10.1159/000341935</pub-id><pub-id pub-id-type="pmid">23112754</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>H</given-names></name><name><surname>Cavallero</surname><given-names>S</given-names></name><name><surname>Estrada</surname><given-names>KD</given-names></name><name><surname>Sandovici</surname><given-names>I</given-names></name><name><surname>Kumar</surname><given-names>SR</given-names></name><name><surname>Makita</surname><given-names>T</given-names></name><name><surname>Lien</surname><given-names>CL</given-names></name><name><surname>Constancia</surname><given-names>M</given-names></name><name><surname>Sucov</surname><given-names>HM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Extracardiac control of embryonic cardiomyocyte proliferation and ventricular wall expansion</article-title><source>Cardiovascular Research</source><volume>105</volume><fpage>271</fpage><lpage>278</lpage><pub-id pub-id-type="doi">10.1093/cvr/cvu269</pub-id><pub-id pub-id-type="pmid">25560321</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>H</given-names></name><name><surname>Gan</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>K</given-names></name><name><surname>Darehzereshki</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>K</given-names></name><name><surname>Ram Kumar</surname><given-names>S</given-names></name><name><surname>Lien</surname><given-names>CL</given-names></name><name><surname>Patterson</surname><given-names>M</given-names></name><name><surname>Tao</surname><given-names>G</given-names></name><name><surname>Sucov</surname><given-names>HM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Mononuclear diploid cardiomyocytes support neonatal mouse heart regeneration in response to paracrine IGF2 signaling</article-title><source>eLife</source><volume>9</volume><elocation-id>24</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.53071</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sibley</surname><given-names>CP</given-names></name><name><surname>Coan</surname><given-names>PM</given-names></name><name><surname>Dean</surname><given-names>W</given-names></name><name><surname>Hughes</surname><given-names>J</given-names></name><name><surname>Smith</surname><given-names>P</given-names></name><name><surname>Reik</surname><given-names>W</given-names></name><name><surname>Burton</surname><given-names>GJ</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Regulates the diffusional exchange characteristics of the mouse placenta</article-title><source>PNAS</source><volume>101</volume><fpage>8204</fpage><lpage>8208</lpage><pub-id pub-id-type="doi">10.1073/pnas.0402508101</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Snider</surname><given-names>P</given-names></name><name><surname>Standley</surname><given-names>KN</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Azhar</surname><given-names>M</given-names></name><name><surname>Doetschman</surname><given-names>T</given-names></name><name><surname>Conway</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Origin of cardiac fibroblasts and the role of periostin</article-title><source>Circulation Research</source><volume>105</volume><fpage>934</fpage><lpage>947</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.109.201400</pub-id><pub-id pub-id-type="pmid">19893021</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Snider</surname><given-names>P</given-names></name><name><surname>Conway</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Probing human cardiovascular congenital disease using transgenic mouse models</article-title><source>Progress in Molecular Biology and Translational Science</source><volume>100</volume><fpage>83</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-384878-9.00003-0</pub-id><pub-id pub-id-type="pmid">21377625</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soellner</surname><given-names>L</given-names></name><name><surname>Kraft</surname><given-names>F</given-names></name><name><surname>Sauer</surname><given-names>S</given-names></name><name><surname>Begemann</surname><given-names>M</given-names></name><name><surname>Kurth</surname><given-names>I</given-names></name><name><surname>Elbracht</surname><given-names>M</given-names></name><name><surname>Eggermann</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Search for cis-acting factors and maternal effect variants in silver-russell patients with ICR1 hypomethylation and their mothers</article-title><source>European Journal of Human Genetics</source><volume>27</volume><fpage>42</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1038/s41431-018-0269-1</pub-id><pub-id pub-id-type="pmid">30218098</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soemedi</surname><given-names>R</given-names></name><name><surname>Wilson</surname><given-names>IJ</given-names></name><name><surname>Bentham</surname><given-names>J</given-names></name><name><surname>Darlay</surname><given-names>R</given-names></name><name><surname>Töpf</surname><given-names>A</given-names></name><name><surname>Zelenika</surname><given-names>D</given-names></name><name><surname>Cosgrove</surname><given-names>C</given-names></name><name><surname>Setchfield</surname><given-names>K</given-names></name><name><surname>Thornborough</surname><given-names>C</given-names></name><name><surname>Granados-Riveron</surname><given-names>J</given-names></name><name><surname>Blue</surname><given-names>GM</given-names></name><name><surname>Breckpot</surname><given-names>J</given-names></name><name><surname>Hellens</surname><given-names>S</given-names></name><name><surname>Zwolinkski</surname><given-names>S</given-names></name><name><surname>Glen</surname><given-names>E</given-names></name><name><surname>Mamasoula</surname><given-names>C</given-names></name><name><surname>Rahman</surname><given-names>TJ</given-names></name><name><surname>Hall</surname><given-names>D</given-names></name><name><surname>Rauch</surname><given-names>A</given-names></name><name><surname>Devriendt</surname><given-names>K</given-names></name><name><surname>Gewillig</surname><given-names>M</given-names></name><name><surname>O’ Sullivan</surname><given-names>J</given-names></name><name><surname>Winlaw</surname><given-names>DS</given-names></name><name><surname>Bu’Lock</surname><given-names>F</given-names></name><name><surname>Brook</surname><given-names>JD</given-names></name><name><surname>Bhattacharya</surname><given-names>S</given-names></name><name><surname>Lathrop</surname><given-names>M</given-names></name><name><surname>Santibanez-Koref</surname><given-names>M</given-names></name><name><surname>Cordell</surname><given-names>HJ</given-names></name><name><surname>Goodship</surname><given-names>JA</given-names></name><name><surname>Keavney</surname><given-names>BD</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Contribution of global rare copy-number variants to the risk of sporadic congenital heart disease</article-title><source>American Journal of Human Genetics</source><volume>91</volume><fpage>489</fpage><lpage>501</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2012.08.003</pub-id><pub-id pub-id-type="pmid">22939634</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spicer</surname><given-names>DE</given-names></name><name><surname>Hsu</surname><given-names>HH</given-names></name><name><surname>Co-Vu</surname><given-names>J</given-names></name><name><surname>Anderson</surname><given-names>RH</given-names></name><name><surname>Fricker</surname><given-names>FJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Ventricular septal defect</article-title><source>Orphanet Journal of Rare Diseases</source><volume>9</volume><elocation-id>144</elocation-id><pub-id pub-id-type="doi">10.1186/s13023-014-0144-2</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subramanian</surname><given-names>A</given-names></name><name><surname>Tamayo</surname><given-names>P</given-names></name><name><surname>Mootha</surname><given-names>VK</given-names></name><name><surname>Mukherjee</surname><given-names>S</given-names></name><name><surname>Ebert</surname><given-names>BL</given-names></name><name><surname>Gillette</surname><given-names>MA</given-names></name><name><surname>Paulovich</surname><given-names>A</given-names></name><name><surname>Pomeroy</surname><given-names>SL</given-names></name><name><surname>Golub</surname><given-names>TR</given-names></name><name><surname>Lander</surname><given-names>ES</given-names></name><name><surname>Mesirov</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles</article-title><source>PNAS</source><volume>102</volume><fpage>15545</fpage><lpage>15550</lpage><pub-id pub-id-type="doi">10.1073/pnas.0506580102</pub-id><pub-id pub-id-type="pmid">16199517</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname><given-names>KE</given-names></name><name><surname>Black</surname><given-names>LD</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The role of cardiac fibroblasts in extracellular matrix-mediated signaling during normal and pathological cardiac development</article-title><source>Journal of Biomechanical Engineering</source><volume>135</volume><elocation-id>71001</elocation-id><pub-id pub-id-type="doi">10.1115/1.4024349</pub-id><pub-id pub-id-type="pmid">23720014</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thorvaldsen</surname><given-names>JL</given-names></name><name><surname>Duran</surname><given-names>KL</given-names></name><name><surname>Bartolomei</surname><given-names>MS</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Deletion of the H19 differentially methylated domain results in loss of imprinted expression of H19 and IGF2</article-title><source>Genes &amp; Development</source><volume>12</volume><fpage>3693</fpage><lpage>3702</lpage><pub-id pub-id-type="doi">10.1101/gad.12.23.3693</pub-id><pub-id pub-id-type="pmid">9851976</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thorvaldsen</surname><given-names>JL</given-names></name><name><surname>Mann</surname><given-names>MRW</given-names></name><name><surname>Nwoko</surname><given-names>O</given-names></name><name><surname>Duran</surname><given-names>KL</given-names></name><name><surname>Bartolomei</surname><given-names>MS</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Analysis of sequence upstream of the endogenous H19 gene reveals elements both essential and dispensable for imprinting</article-title><source>Molecular and Cellular Biology</source><volume>22</volume><fpage>2450</fpage><lpage>2462</lpage><pub-id pub-id-type="doi">10.1128/MCB.22.8.2450-2462.2002</pub-id><pub-id pub-id-type="pmid">11909940</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thorvaldsen</surname><given-names>JL</given-names></name><name><surname>Fedoriw</surname><given-names>AM</given-names></name><name><surname>Nguyen</surname><given-names>S</given-names></name><name><surname>Bartolomei</surname><given-names>MS</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Developmental profile of H19 differentially methylated domain (DMD) deletion alleles reveals multiple roles of the DMD in regulating allelic expression and DNA methylation at the imprinted H19/igf2 locus</article-title><source>Molecular and Cellular Biology</source><volume>26</volume><fpage>1245</fpage><lpage>1258</lpage><pub-id pub-id-type="doi">10.1128/MCB.26.4.1245-1258.2006</pub-id><pub-id pub-id-type="pmid">16449639</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ueno</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>LK</given-names></name><name><surname>Chhabra</surname><given-names>A</given-names></name><name><surname>Kim</surname><given-names>YJ</given-names></name><name><surname>Sasidharan</surname><given-names>R</given-names></name><name><surname>Van Handel</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Kamata</surname><given-names>M</given-names></name><name><surname>Kamran</surname><given-names>P</given-names></name><name><surname>Sereti</surname><given-names>KI</given-names></name><name><surname>Ardehali</surname><given-names>R</given-names></name><name><surname>Jiang</surname><given-names>M</given-names></name><name><surname>Mikkola</surname><given-names>HKA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>C-met-dependent multipotent labyrinth trophoblast progenitors establish placental exchange interface</article-title><source>Developmental Cell</source><volume>27</volume><fpage>373</fpage><lpage>386</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2013.10.019</pub-id><pub-id pub-id-type="pmid">24286824</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vega-Hernández</surname><given-names>M</given-names></name><name><surname>Kovacs</surname><given-names>A</given-names></name><name><surname>De Langhe</surname><given-names>S</given-names></name><name><surname>Ornitz</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>FGF10/fgfr2b signaling is essential for cardiac fibroblast development and growth of the myocardium</article-title><source>Development</source><volume>138</volume><fpage>3331</fpage><lpage>3340</lpage><pub-id pub-id-type="doi">10.1242/dev.064410</pub-id><pub-id pub-id-type="pmid">21750042</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>von Gise</surname><given-names>A</given-names></name><name><surname>Pu</surname><given-names>WT</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Endocardial and epicardial epithelial to mesenchymal transitions in heart development and disease</article-title><source>Circulation Research</source><volume>110</volume><fpage>1628</fpage><lpage>1645</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.111.259960</pub-id><pub-id pub-id-type="pmid">22679138</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vrooman</surname><given-names>LA</given-names></name><name><surname>Rhon-Calderon</surname><given-names>EA</given-names></name><name><surname>Chao</surname><given-names>OY</given-names></name><name><surname>Nguyen</surname><given-names>DK</given-names></name><name><surname>Narapareddy</surname><given-names>L</given-names></name><name><surname>Dahiya</surname><given-names>AK</given-names></name><name><surname>Putt</surname><given-names>ME</given-names></name><name><surname>Schultz</surname><given-names>RM</given-names></name><name><surname>Bartolomei</surname><given-names>MS</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Assisted reproductive technologies induce temporally specific placental defects and the preeclampsia risk marker sflt1 in mouse</article-title><source>Development</source><volume>147</volume><elocation-id>dev186551</elocation-id><pub-id pub-id-type="doi">10.1242/dev.186551</pub-id><pub-id pub-id-type="pmid">32471820</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wakeling</surname><given-names>EL</given-names></name><name><surname>Brioude</surname><given-names>F</given-names></name><name><surname>Lokulo-Sodipe</surname><given-names>O</given-names></name><name><surname>O’Connell</surname><given-names>SM</given-names></name><name><surname>Salem</surname><given-names>J</given-names></name><name><surname>Bliek</surname><given-names>J</given-names></name><name><surname>Canton</surname><given-names>APM</given-names></name><name><surname>Chrzanowska</surname><given-names>KH</given-names></name><name><surname>Davies</surname><given-names>JH</given-names></name><name><surname>Dias</surname><given-names>RP</given-names></name><name><surname>Dubern</surname><given-names>B</given-names></name><name><surname>Elbracht</surname><given-names>M</given-names></name><name><surname>Giabicani</surname><given-names>E</given-names></name><name><surname>Grimberg</surname><given-names>A</given-names></name><name><surname>Grønskov</surname><given-names>K</given-names></name><name><surname>Hokken-Koelega</surname><given-names>ACS</given-names></name><name><surname>Jorge</surname><given-names>AA</given-names></name><name><surname>Kagami</surname><given-names>M</given-names></name><name><surname>Linglart</surname><given-names>A</given-names></name><name><surname>Maghnie</surname><given-names>M</given-names></name><name><surname>Mohnike</surname><given-names>K</given-names></name><name><surname>Monk</surname><given-names>D</given-names></name><name><surname>Moore</surname><given-names>GE</given-names></name><name><surname>Murray</surname><given-names>PG</given-names></name><name><surname>Ogata</surname><given-names>T</given-names></name><name><surname>Petit</surname><given-names>IO</given-names></name><name><surname>Russo</surname><given-names>S</given-names></name><name><surname>Said</surname><given-names>E</given-names></name><name><surname>Toumba</surname><given-names>M</given-names></name><name><surname>Tümer</surname><given-names>Z</given-names></name><name><surname>Binder</surname><given-names>G</given-names></name><name><surname>Eggermann</surname><given-names>T</given-names></name><name><surname>Harbison</surname><given-names>MD</given-names></name><name><surname>Temple</surname><given-names>IK</given-names></name><name><surname>Mackay</surname><given-names>DJG</given-names></name><name><surname>Netchine</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Diagnosis and management of silver-russell syndrome: first international consensus statement</article-title><source>Nature Reviews. Endocrinology</source><volume>13</volume><fpage>105</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.1038/nrendo.2016.138</pub-id><pub-id pub-id-type="pmid">27585961</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>X</given-names></name><name><surname>Sun</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The functions of lncrna H19 in the heart</article-title><source>In Heart Lung and Circulation</source><pub-id pub-id-type="doi">10.1016/j.hlc.2021.10.022</pub-id><pub-id pub-id-type="pmid">34840062</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woods</surname><given-names>L</given-names></name><name><surname>Perez-Garcia</surname><given-names>V</given-names></name><name><surname>Hemberger</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Regulation of placental development and its impact on fetal growth-new insights from mouse models</article-title><source>Frontiers in Endocrinology</source><volume>9</volume><fpage>1</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.3389/fendo.2018.00570</pub-id><pub-id pub-id-type="pmid">30319550</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Jaenisch</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Generating genetically modified mice using CRISPR/cas-mediated genome engineering</article-title><source>Nature Protocols</source><volume>9</volume><fpage>1956</fpage><lpage>1968</lpage><pub-id pub-id-type="doi">10.1038/nprot.2014.134</pub-id><pub-id pub-id-type="pmid">25058643</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.78754.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Yan</surname><given-names>Wei</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/046rm7j60</institution-id><institution>University of California, Los Angeles</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><related-object id="sa0ro1" object-id-type="id" object-id="10.1101/2022.03.28.486058" link-type="continued-by" xlink:href="https://sciety.org/articles/activity/10.1101/2022.03.28.486058"/></front-stub><body><p>This important study took advantage of multiple mouse models with varying levels of H19 and Igf2 expression to dissect the role of H19 and Igf2 in cardiac and placental development. This work links the heart and placenta through regulation by H19 and Igf2, demonstrating that an accurate dosage of both H19 and Igf2 is critical for normal embryonic development, especially related to the cardiac-placental axis. The topic is of significance, and the data are of high quality and convincing.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.78754.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Yan</surname><given-names>Wei</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/046rm7j60</institution-id><institution>University of California, Los Angeles</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Sferruzzi-Perri</surname><given-names>Amanda N</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/013meh722</institution-id><institution>University of Cambridge</institution></institution-wrap><country>United Kingdom</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2022.03.28.486058">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2022.03.28.486058v1">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Dysregulated <italic>H19/Igf2</italic> expression disrupts cardiac-placental axis during development of Silver Russell Syndrome-like mouse models&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Marianne Bronner as the Senior Editor. The following individual involved in the review of your submission has agreed to reveal their identity: Amanda N Sferruzzi-Perri (Reviewer #3).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>1) A tetraploid aggregation experiment in which the placental trophoblast lineage is rescued in at least one of the models, ideally the +/hIC1 mice.</p><p>2) The molecular interactions between H19 and Igf2 should be explored if possible.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>Work on the genetic dissection of effects of either individual or combined dysregulation of H19 and Igf2 on cardiac and placental development was well done. However, the molecular interactions between H19 and Igf2 were not explored. With multiple genetic models in hand, it would be interesting to examine changes in miRNAs and H19 lncRNAs as well as Igf2 expression levels to determine whether the existing notions (miR-645 produced from H19 lncRNA targets Igf2) are correct or not; it can also lead to novel mechanistic insight into interactions between H19 and Igf2.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>This is a well-written and thoroughly conducted study by a world-leading team that has specialized in the fine analysis of Igf2 and H19 regulation and function.</p><p>In addition to the data provided, the study would be immensely strengthened by a tetraploid aggregation approach in which the placental trophoblast lineage is rescued in at least one of the models, ideally the +/hIC1 mice. This experiment would identify whether the hemorrhagic areas in the placenta are caused by endothelial cell dysfunction, or conversely whether the heart defects are fully or partially caused by trophoblast dysfunction.</p><p>In addition to the comments in the public review, the use of bean plots is not always the best display. In particular, the diagram on Mendelian ratios is clear where the 'bean' reaches negative values. A simple scatter plot or box plot display will be fine.</p><p>Placental histology must be improved, and robust vascular staining images supplied.</p><p>Figure 4D bottom right, the heart is sectioned at an angle, please replace this specimen with a more suitable example.</p><p><italic>Reviewer #3 (Recommendations for the authors):</italic></p><p>1. Line 69-72; 'Although the epigenetic defects and growth restriction of these mice model SRS, the epigenetic defects in human are mosaic (Soellner et al., 2019), with a subset of cells showing normal methylation patterns, providing a potential explanation for why SRS individuals are viable.' Reword to increase clarity.</p><p>2. Line 91-92: 'Normalization of H19 rescued neither the lethality nor growth restriction, although we observed a minimal rescue of the earlier growth and resorption frequency.' Reword to increase clarity.</p><p>3. L119 milk spots where? In their abdomen?</p><p>4. It is excellent that the authors used litter means for their statistical analyses. This robust method should be applied to Figure 3B, which should represent litter means, not individual fetuses.</p><p>5. Figure 3C and H: what do the violin plots represent? Confidence intervals? What is the sex of the fetuses shown in 3G? please state in legend. Part of Figure 3H x-axis label cant be seen. Was microvessel density also only reduced in +/hIC1 males?</p><p>6. When do the defects in the placenta microvasculature appear relative to the heart defects in +/hIC1? Were growth and heart defects more common/severe in males?</p><p>7. All figures, including supplementary should have the y-axes starting at 0 – which is better for identifying the magnitude of the change. They should all include information on the number of litters used and employ litter averages for statistics (eg Supp Figure 3D is unclear).</p><p>8. Text stating Data not shown: Please show all data or do not describe it.</p><p>9. Using in silico/bioinformatic analysis, are the authors able to estimate what proportion of the DEGs may be directly (vs indirectly) modified by the H19 ncRNA in the relevant mutants?</p><p>10. I realise it is out of the scope of the paper, but it would have been amazing to have undertaken similar transcriptomic analyses of the placenta at E12.5 – to assess how the placenta and heart may similarly or differentially respond to the H19/Igf2 gene alterations. Moreover, undertaking placental or cardiac-specific gene manipulations would inform further on the nature of the plac-heart axis and how it may be mediated through changes in the H19/Igf2 imprinted locus. Descriptions of these future studies should be included in the discussion.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.78754.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) A tetraploid aggregation experiment in which the placental trophoblast lineage is rescued in at least one of the models, ideally the +/hIC1 mice.</p></disp-quote><p>See Reviewer 2, point 1.</p><disp-quote content-type="editor-comment"><p>2) The molecular interactions between H19 and Igf2 should be explored if possible.</p></disp-quote><p>See Reviewer 1, point 1</p><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>Work on the genetic dissection of effects of either individual or combined dysregulation of H19 and Igf2 on cardiac and placental development was well done. However, the molecular interactions between H19 and Igf2 were not explored. With multiple genetic models in hand, it would be interesting to examine changes in miRNAs and H19 lncRNAs as well as Igf2 expression levels to determine whether the existing notions (miR-645 produced from H19 lncRNA targets Igf2) are correct or not; it can also lead to novel mechanistic insight into interactions between H19 and Igf2.</p></disp-quote><p>In order to determine if the level of <italic>Mir675</italic> is correlated with changes in <italic>H19</italic> and <italic>Igf2</italic> expression<italic>,</italic> we examined the <italic>Mir675</italic> expression in <italic>+/hIC1</italic> placenta at E15.5 (Figure 3—figure supplement 1E). Although increased <italic>H19</italic> expression together with <italic>Igf2</italic> depletion was present in E15.5 +/hIC1 placentas (Hur et al., 2016), <italic>Mir675</italic> was not significantly increased in <italic>+/hIC1</italic> placentas compared to the wild-type. Thus, the placental phenotypes observed in <italic>+/hIC1</italic> mice are solely attributable to the increased <italic>H19</italic> lncRNA, irrespective of <italic>Mir675</italic>. This information was added to lines 173-183. Associated methods were also added to lines 446-450.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>1. In addition to the data provided, the study would be immensely strengthened by a tetraploid aggregation approach in which the placental trophoblast lineage is rescued in at least one of the models, ideally the +/hIC1 mice. This experiment would identify whether the hemorrhagic areas in the placenta are caused by endothelial cell dysfunction, or conversely whether the heart defects are fully or partially caused by trophoblast dysfunction.</p></disp-quote><p>As requested, we performed tetraploid aggregation experiments to test if wild-type placental trophoblast lineage could rescue the cardiac defects of <italic>+/hIC1</italic> embryos. The experimental method was described further in the figure A below and ‘Materials and methods’ below. Briefly, tetraploid (4N) cells, that were derived from wild-type 2-cell embryos, were aggregated with diploid (2N) embryos from mating between wild-type females and <italic>hIC1/+</italic> males (Tanaka et al., 2009). The <italic>hIC1/+</italic> males were homozygous for GFP inserted at <italic>Oct4</italic> locus (Lengner et al., 2007). Therefore, the absence of GFP in the extraembryonic gDNA would indicate that the extraembryonic tissue originated from the 4N cells, which did not contain GFP. Aggregated blastocysts were transferred into recipient females, and embryos and placentas were weighed and collected at E15.5 and E17.5 for further analysis.</p><p>It is known that in tetraploid aggregation, 2N cells are capable of contributing to both embryonic and extraembryonic tissues without restriction, although contribution from 4N cells is restricted to extraembryonic tissues (Tanaka et al., 2009). Therefore, our aggregated placenta will be chimeric for wild-type and <italic>+/hIC1</italic> cells in the best case. As expected, no placenta was fully derived from the wild-type 4N cells. In order to estimate the contribution of 4N cells, we performed qPCR analysis of hIC1 and/or GFP in embryonic and placental gDNA. For all experiments (at least 3 attempts at E17.5 and 1 attempt at E15.5), hIC1 and/or GFP gDNA was detected in both the embryo and placenta, indicating that 2N embryonic cells contributed to the formation of extraembryonic tissue.</p><p>At E17.5, we recovered four <italic>+/hIC1</italic> embryos with placenta containing 4N wild-type cells. In all four E17.5 embryos, the level of hIC1 was higher in embryonic gDNA compared to placental gDNA, indicating that 4N wild-type cells are contributing to these placentas (<xref ref-type="fig" rid="sa2fig1">Author response image 1B</xref>, left). In samples containing a GFP allele in 2N cells, we measured the level of GFP in embryonic and placental gDNA, as only in 2N cells but not in 4N cells had GFP. In these E17.5 recovered embryos, GFP-positive 2N cells always contributed to the placenta (<xref ref-type="fig" rid="sa2fig1">Author response image 1B</xref>, right). We did not observe rescue in fetal weight (<xref ref-type="fig" rid="sa2fig1">Author response image 1C</xref>) or cardiac and placental morphologies in the <italic>+/hIC1</italic> embryos, irrespective of the level of 4N wild-type cells in the placenta. Large thrombi were observed in placentas of <italic>+/hIC1</italic> embryos that were aggregated with 4N wild-type cells (<xref ref-type="fig" rid="sa2fig1">Author response image 1D</xref>). Such lesions were not found in placentas of wild-type embryos from the same aggregation (<xref ref-type="fig" rid="sa2fig1">Author response image 1E</xref>). Thus, the aggregated 4N wild-type cells did not rescue the placental morphology, even when the contribution of 2N <italic>+/hIC1</italic> cells to placenta was extremely low. As the placental defects were not rescued, it would be impossible to conclude whether or not placental dysfunction is causing the <italic>+/hIC1-</italic>associated cardiac defects utilizing these embryos. The varying contribution of 2N cells to placenta was also observed at E15.5. This was confirmed through measuring levels of hIC1 and GFP in embryonic versus placental gDNA (<xref ref-type="fig" rid="sa2fig1">Author response image 1F</xref>). Regardless of the level of contribution of wild-type 4N cells to the placenta, the embryonic and placental undergrowth as well as cardiac defects persisted in these embryos (<xref ref-type="fig" rid="sa2fig1">Author response image 1G</xref>).</p><p>We also aggregated 2N wild-type cells with 4N <italic>+/hIC1</italic> cells to test if <italic>+/hIC1</italic> placenta is sufficient to cause cardiac defects in embryos. However, out of 20 embryos we recovered at E17.5, only one embryo was found to have <italic>+/hIC1</italic> cells in its placenta, and the level of hIC1 in its placental gDNA was less than 7.5% of the hIC1 level in normal <italic>+/hIC1</italic> placentas. Therefore, this embryo was not suitable to test the effect of <italic>+/hIC1</italic> placentas on the cardiac development of the embryo.</p><p>In conclusion, we were fortunate to have a colleague who could perform the requested aggregation experiments and were quite hopeful regarding this line of experimentation. Nevertheless, although we spent the revision period addressing the reviewer request, we do not feel confident in stating whether the phenotypes originate from the heart (endothelial cells) or placenta (trophoblast cells). Optimally, an experiment in which the embryo or placenta were entirely derived with the hIC1 allele would be the best test see text at end of discussion and Review 3 response (Point 10). However, because the allele was quite complicated to obtain and transmit due to the lethality of the paternal-specific insertion, this experiment is not possible.</p><fig id="sa2fig1" position="float"><label>Author response image 1.</label><caption><title>Tetraploid aggregation experiment.</title><p>(<bold>A</bold>) Schematic description of tetraploid aggregation experiment. (<bold>B</bold>) Level of hIC1 and GFP in embryonic and placental gDNA from hIC1 aggregated samples. (<bold>C</bold>) Embryonic and placental weight of E17.5 aggregated samples. (<bold>D</bold>) Representative cross-sections of E17.5 4N wild-type placentas with <italic>+/hIC1</italic> embryos stained with hematoxylin and eosin. Black arrowhead indicates a large thrombus formed in the <italic>+/hIC1</italic> labyrinth. (<bold>E</bold>) Representative cross-sections of E17.5 4N wild-type placentas with <italic>+/hIC1</italic> embryos stained with hematoxylin and eosin. (<bold>F</bold>) (<bold>G</bold>) (<bold>D, E</bold>) Scale bars = 1mm. (<bold>B, C, G</bold>) Each data point represents an individual conceptus from different aggregated litters. Statistics used are (<bold>B, C, G</bold>) multiple unpaired t-test. *P &lt; 0.05, **P &lt; 0.01, ***P &lt; 0.001, ****P &lt; 0.0001, ns = not significant.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78754-sa2-fig1-v1.tif"/></fig><p>“Materials and methods:</p><p>The embryos used for this experiment were collected from 4-6 week old C57BL/6 females. The females were superovulated using 5 IU of pregnant mare serum gonadotropin (PMSG) followed 48 hours later by 5 IU of human chorionic gonadotropin (hCG) after which they were mated to C57Bl6 and hlC1studs. For latter experiments, the <italic>hIC1/+</italic> stud males were also homozygous for a GFP knock-in allele (Lengner et al., 2007). All the hormones were administrated via intraperitoneal injection (IP).</p><p>The 2-cell embryos used for the aggregation experiment were collected from the oviduct about 42 hours post hCG. To generate the tetraploid embryos, 2-cell embryo blastomeres were fused together by using a CF-150/B cell fusing apparatus (voltage: DC 9; mico second 40; pulse 1). Only the embryos in which the blastomeres successfully fused were considered tetraploid embryos and were aggregated with the diploid embryos. The embryos were aggregated at the 2 and 4 cell stage. The zona pellucida was removed from both the diploid and tetraploid embryos with acidic tyrodes solution (EmbryoMax, cat# MR-004-D) and after removal, one diploid and one tetraploid embryo were placed together in a small dimple made in the plastic dish. The dimples were made using the aggregation needles (type:DN-09). About 20 aggregated embryo pairs were cultured per culture drop. All the aggregates were cultured until the blastocyst stage in a 5% O2, 5% CO2 incubator using KSOM media (Millipore, MR-202P-5F). The KSOM culture drops were covered with mineral oil (Millipore, ES-005-C) to prevent evaporation. Only the successfully aggregated embryos were transferred into Swiss Webster pseudo-pregnant recipient females which were synchronized by using Swiss Webster vasectomized males.</p><p>Embryo collection, embryo fusion and embryo transfers were performed at room temperature in HEPES-buffered CZB medium (PVP 0.1% w/v; albumin-free). We weighed embryos and placentas and collected heart and placenta for histology. We collected embryonic tissues and placenta for genotyping.”</p><disp-quote content-type="editor-comment"><p>2. The use of bean plots is not always the best display. In particular, the diagram on Mendelian ratios is clear where the 'bean' reaches negative values. A simple scatter plot or box plot display will be fine.</p></disp-quote><p>As recommended, we have replaced all of the bean/violin plots presented in (Figure 2B, 3C, 3H and 4B; Figure 4—figure supplement 2A and Figure 5—figure supplement 1C) with scatter plots.</p><disp-quote content-type="editor-comment"><p>3. Figure 4D bottom right, the heart is sectioned at an angle, please replace this specimen with a more suitable example.</p></disp-quote><p>As requested, we have replaced the angled E17.5 <italic>dH19/hIC1</italic> heart image in Figure 4D with a more suitable example.</p><disp-quote content-type="editor-comment"><p>Reviewer #3 (Recommendations for the authors):</p><p>1. Line 69-72; 'Although the epigenetic defects and growth restriction of these mice model SRS, the epigenetic defects in human are mosaic (Soellner et al., 2019), with a subset of cells showing normal methylation patterns, providing a potential explanation for why SRS individuals are viable.' Reword to increase clarity.</p></disp-quote><p>We have reworded Lines 69-72 to: ‘Although the epigenetic defects and growth restriction of these mice nicely model SRS symptoms, many SRS individuals are viable. A potential explanation for such discrepancy between human and mouse could reflect the mosaic nature of epigenetic defects in human (Soellner et al., 2019), with a subset of cells showing normal methylation patterns.’ (see Lines 71-75).</p><disp-quote content-type="editor-comment"><p>2. Line 91-92: 'Normalization of H19 rescued neither the lethality nor growth restriction, although we observed a minimal rescue of the earlier growth and resorption frequency.' Reword to increase clarity.</p></disp-quote><p>We have reworded Lines 91-92 to:</p><p>‘Deletion of <italic>H19</italic> from the maternal allele, thereby reducing <italic>H19</italic> levels, failed to rescue completely the lethality and growth restriction associated with the paternal inheritance of hIC1. A minimal rescue of the earlier growth and resorption frequency was, however, observed with normalized <italic>H19</italic> expression.’ (see lines 94-96).</p><disp-quote content-type="editor-comment"><p>3. L119 milk spots where? In their abdomen?</p></disp-quote><p>To Line 119, location of milk spots has been added: ‘….milk spots were found in their abdomen,…’ (see line 123).</p><disp-quote content-type="editor-comment"><p>4. It is excellent that the authors used litter means for their statistical analyses. This robust method should be applied to Figure 3B, which should represent litter means, not individual fetuses.</p></disp-quote><p>The graph in Figure 3B was edited and now represents litter means. The following statement was added to the figure legend: ‘Each data point represents an average F/P ratio of each genotype from one litter. 13 litters are presented.’</p><disp-quote content-type="editor-comment"><p>5. Figure 3C and H: what do the violin plots represent? Confidence intervals? What is the sex of the fetuses shown in 3G? please state in legend. Part of Figure 3H x-axis label cant be seen. Was microvessel density also only reduced in +/hIC1 males?</p></disp-quote><p>We have replaced the violin plots in Figure 3C and H with simple scatter plots presenting mean with SD (also recommended by reviewer #2, Point 9), to be consistent with the presentation of other plots including Figure 3A, 3B and 3D. The distribution of individual samples can now be observed. In Figure 3G, the wild-type fetus is female and <italic>+/hIC1</italic> fetus is male. This information was added to the figure legend. The decrease in microvessel density was statistically significant only in <italic>+/hIC1</italic> male placentas. Still, <italic>+/hIC1</italic> female placentas showed a trend to reduced microvessel density compared to the wild-type, although to less extent and not statistically significant. We have also separated the wild-type male and female samples in Figure 3H to make the sex specific comparisons of microvessel density (Figure 3H; also see lines 162-164).</p><disp-quote content-type="editor-comment"><p>6. When do the defects in the placenta microvasculature appear relative to the heart defects in +/hIC1? Were growth and heart defects more common/severe in males?</p></disp-quote><p>The placental microvasculature defects were observed later than cardiac defects. At E12.5, which is the earliest stage when the cardiac defects were observed, CD34 staining showed that <italic>+/hIC1</italic> placentas do not have a significant difference in microvasculature structures compared to the wild-type. Growth and heart defects were not affected by the sex of the embryo.</p><disp-quote content-type="editor-comment"><p>7. All figures, including supplementary should have the y-axes starting at 0 – which is better for identifying the magnitude of the change. They should all include information on the number of litters used and employ litter averages for statistics (eg Supp Figure 3D is unclear).</p></disp-quote><p>Figures were edited accordingly. The information about the number of litters was added to the figure legends. As requested, we adjusted y-axis to start at 0 in all graphs (Figure 4F, Figure 4—figure supplement 2A and Figure 5-figue supplement 1A). In the figure legend for Figure 4—figure supplement 1D, we added requested information: ‘Embryonic and neonatal body weight of the wild-type (blue) and △H19/+ (green) samples at E11.5, E12.5, E14.5, E17.5, E18.5 and PN0 (mean ± SD). 6 litters for E11.5, 6 litters for E12.5, 3 litters for E14.5, 11 litters for E17.5, 3 litters for E18.5,14 litters for PN0 are presented. (E) Body weight of +/△H19 neonates (mean ± SD). 3 litters are presented.’</p><disp-quote content-type="editor-comment"><p>8. Text stating Data not shown: Please show all data or do not describe it.</p></disp-quote><p>As requested, we have removed/replaced four ‘data not shown’ in the previously submitted documents (at indicated Line) as follows:</p><p>Line 121: We deleted ‘In contrast to the liver where the paternal hIC1 did not lead to significant</p><p>abnormal morphology (data not shown),’.</p><p>Line 177: We deleted ‘and data not shown’. (see line 196)</p><p>Line 195: We replaced ‘Figure 4D and data not shown’ with ‘see Figure 4D for example’. (see lines 214-215)</p><p>Line 378: We replaced ‘data not shown’ with ‘Figure 6—figure supplement 5. (see line 398 and Figure 6—figure supplement 5)</p><disp-quote content-type="editor-comment"><p>9. Using in silico/bioinformatic analysis, are the authors able to estimate what proportion of the DEGs may be directly (vs indirectly) modified by the H19 ncRNA in the relevant mutants?</p></disp-quote><p>Because our mouse models are not linear with respect to <italic>H19</italic> overexpression, it is difficult to make a direct correlation between the level of <italic>H19</italic> expression and which genes are altered. However, data in Figure 6—figure supplement 2 and 3, where we compared <italic>+/hIC1, △H19/hIC1,</italic> and <italic>△H19/+</italic> endothelial cells to identify the genes whose expression is solely affected by the increased <italic>H19</italic>, suggest that <italic>H19</italic> affected a certain group of DEGs such as <italic>Fgf10</italic> or the imprinted gene network, independently of the loss of <italic>Igf2</italic> (also see lines 281-307).</p><disp-quote content-type="editor-comment"><p>10. I realise it is out of the scope of the paper, but it would have been amazing to have undertaken similar transcriptomic analyses of the placenta at E12.5 – to assess how the placenta and heart may similarly or differentially respond to the H19/Igf2 gene alterations. Moreover, undertaking placental or cardiac-specific gene manipulations would inform further on the nature of the plac-heart axis and how it may be mediated through changes in the H19/Igf2 imprinted locus. Descriptions of these future studies should be included in the discussion.</p></disp-quote><p>We agree with the reviewer and appreciate the insight. The suggestion was reflected on our discussion and a future experiment would be to profile transcriptomic changes in placental cells of our mouse models, as reflected in the following added text: “Transcriptomic analysis of fetoplacental endothelial cells from our mouse models would help us understand the role of <italic>H19/Igf2</italic> in placental development. Moreover, generating a tissue-specific <italic>hIC1</italic> mouse model, if possible, would allow us to determine the causal relationship between cardiac and placental phenotypes.” (see lines 420-423).</p><p>References</p><p>Esquiliano, D. R., Guo, W., Liang, L., Dikkes, P., &amp; Lopez, M. F. (2009). Placental Glycogen Stores are Increased in Mice with H19 Null Mutations but not in those with Insulin or IGF Type 1 Receptor Mutations. <italic>Placenta</italic>, <italic>30</italic>(8). https://doi.org/10.1016/j.placenta.2009.05.004</p><p>Hur, S. K., Freschi, A., Ideraabdullah, F., Thorvaldsen, J. L., Luense, L. J., Weller, A. H., Berger, S. L., Cerrato, F., Riccio, A., &amp; Bartolomei, M. S. (2016). Humanized H19/Igf2 locus reveals diverged imprinting mechanism between mouse and human and reflects Silver-Russell syndrome phenotypes. <italic>Proceedings of the National Academy of Sciences of the United States of America</italic>. https://doi.org/10.1073/pnas.1603066113</p><p>Lengner, C. J., Camargo, F. D., Hochedlinger, K., Welstead, G. G., Zaidi, S., Gokhale, S., Scholer, H. R., Tomilin, A., &amp; Jaenisch, R. (2007). Oct4 Expression Is Not Required for Mouse Somatic Stem Cell Self-Renewal. <italic>Cell Stem Cell</italic>, <italic>1</italic>(4). https://doi.org/10.1016/j.stem.2007.07.020</p><p>Lopez, M. F., Dikkes, P., Zurakowski, D., &amp; Villa-Komaroff, L. (1996). Insulin-like growth factor II affects the appearance and glycogen content of glycogen cells in the murine placenta. <italic>Endocrinology</italic>, <italic>137</italic>(5). https://doi.org/10.1210/endo.137.5.8612553</p><p>Sakata, Y., Kamei, C. N., Nakagami, H., Bronson, R., Liao, J. K., &amp; Chin, M. T. (2002). Ventricular septal defect and cardiomyopathy in mice lacking the transcription factor CHF1/HEY2. <italic>Proceedings of the National Academy of Sciences of the United States of America</italic>, <italic>99</italic>(25). https://doi.org/10.1073/pnas.252648999</p><p>Tanaka, M., Hadjantonakis, A. K., Vintersten, K., &amp; Nagy, A. (2009). Aggregation chimeras: Combining es cells, diploid, and tetraploid embryos. <italic>Methods in Molecular Biology</italic>, <italic>530</italic>. https://doi.org/10.1007/978-1-59745-471-1_15</p></body></sub-article></article>